###begin article-title 0
Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells
###end article-title 0
###begin p 1
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 223 224 211 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 288 289 276 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 358 359 346 347 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 618 619 591 592 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 769 770 742 743 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 852 853 825 826 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1019 1020 988 989 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1136 1137 1105 1106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1230 1231 1199 1200 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 326 331 <span type="species:ncbi:9606">human</span>
Select changes in microRNA (miRNA) expression correlate with estrogen receptor alpha (ERalpha) expression in breast tumors. miR-21 is higher in ERalpha positive than negative tumors, but no one has examined how estradiol (E2) regulates miR-21 in breast cancer cells. Here we report that E2 inhibits miR-21 expression in MCF-7 human breast cancer cells. The E2-induced reduction in miR-21 was inhibited by 4-hydroxytamoxifen (4-OHT), ICI 182 780 (Faslodex), and siRNA ERalpha indicating that the suppression is ERalpha-mediated. ERalpha and ERbeta agonists PPT and DPN inhibited and 4-OHT increased miR-21 expression. E2 increased luciferase activity from reporters containing the miR-21 recognition elements from the 3'-UTRs of miR-21 target genes, corroborating that E2 represses miR-21 expression resulting in a loss of target gene suppression. The E2-mediated decrease in miR-21 correlated with increased protein expression of endogenous miR-21-targets Pdcd4, PTEN and Bcl-2. siRNA knockdown of ERalpha blocked the E2-induced increase in Pdcd4, PTEN and Bcl-2. Transfection of MCF-7 cells with antisense (AS) to miR-21 mimicked the E2-induced increase in Pdcd4, PTEN and Bcl-2. These results are the first to demonstrate that E2 represses the expression of an oncogenic miRNA, miR-21, by activating estrogen receptor in MCF-7 cells.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 461 462 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 472 473 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 592 593 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 693 694 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 748 749 734 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 897 898 883 884 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 937 938 923 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 939 940 925 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
Although the precise sequence of events leading to breast tumors are not understood, lifetime exposure to estrogens is widely accepted as a major risk factor for the development of breast cancer. Estrogens promote cell replication by binding to the estrogen receptors alpha and beta (ERalpha and ERbeta). Ligand-activated ER acts genomically by binding directly to estrogen response elements (EREs) or by a 'tethering mechanism', e.g. by interacting with AP-1 (1) or Sp1 (2). These interactions recruit coregulators to initiate chromatin remodeling resulting in increased gene transcription (3). ER can also suppress target gene transcription, although the mechanisms involved are unresolved (4). In addition to its ER-mediated, genomic activity, E2 also has 'non-genomic' or 'membrane-initiated' effects, i.e. independent of ER-mediated transcription, that occur within minutes after estradiol (E2), or other ER ligand, administration (5,6).
###end p 4
###begin p 5
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 450 451 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 683 684 683 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 111 116 <span type="species:ncbi:9606">women</span>
###xml 240 245 <span type="species:ncbi:9606">women</span>
###xml 673 681 <span type="species:ncbi:9606">patients</span>
Inhibition of estrogen action is used as the adjuvant therapy of choice to treat both pre- and post-menopausal women with breast cancer. The anti-estrogen/Selective ER Modulator (SERM) tamoxifen (TAM) is the 'gold standard' of treatment of women with ER positive tumors (7). TAM is a SERM because it has mixed agonist/antagonist activity in a cell- and gene-specific manner whereas Faslodex (Fulvestrant, ICI 182 780) has pure antiestrogen activity (8). Ablation of endogenous estrogen production using aromatase inhibitors (AIs, e.g. anastrozole, letrozole and exemestane) has an efficacy greater than TAM in preventing disease recurrence in post-menopausal breast cancer patients (9). Together, these data demonstrate the importance of endogenous estrogens in promoting breast cancer recurrence.
###end p 5
###begin p 6
###xml 134 139 134 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10 B11 B12">10&#8211;12</xref>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
MicroRNAs (miRNAs) are a class of naturally occurring, small, non-coding RNA molecules distinct from small interfering RNAs (siRNAs) (10-12). miRNA genes are mostly transcribed by RNA polymerase II, processed by Drosha into short hairpin RNAs that are exported from the nucleus, and processed by Dicer to form mature 21-25 nucleotide miRNAs which are transferred to Argonaute proteins in RISC. miRNAs bind to the 3'-untranslated region (3' UTR) of target mRNAs and either block the translation of the message or target the mRNA transcript to be degraded (13). miRNAs may also increase translation of select mRNAs in a cell cycle-dependent manner (14).
###end p 6
###begin p 7
###xml 39 41 39 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 174 176 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 260 265 248 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16 B17 B18 B19 B20 B21 B22 B23 B24 B25 B26 B27 B28 B29 B30 B31 B32 B33 B34 B35 B36 B37 B38 B39 B40">16&#8211;40</xref>
###xml 348 357 336 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 430 432 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 487 489 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 564 569 552 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 606 608 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 731 733 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 806 808 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 840 841 820 821 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 239 244 <span type="species:ncbi:9606">human</span>
###xml 558 563 <span type="species:ncbi:9606">human</span>
###xml 881 886 <span type="species:ncbi:9606">human</span>
The human genome contains >700 miRNAs (15) and miRNAs are expressed in a tissue-specific manner (16). Each miRNA targets approximately200 transcripts directly or indirectly (17). Aberrant patterns of miRNA expression have been reported in human breast cancer (16-40). A number of genes involved in breast cancer progression have been identified by in silico analysis to be targets of miRNAs that are deregulated in breast cancer (41) and some, e.g. AIB1 have been experimentally proven (42). We recently reported that miR-21 downregulates the translation of human PDCD4, a tumor suppressor in MCF-7 cells (43). Although miR-21 was identified as an 'oncomiR', was the most significantly up-regulated miRNA in breast tumor biopsies (37), and was significantly higher in ERalpha+ than ERalpha- breast tumors (40), no one has examined whether E2 or SERMs regulate miR-21 expression in human breast cancer cells.
###end p 7
###begin p 8
###xml 84 85 84 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 126 127 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 183 184 183 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 263 264 263 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 287 296 287 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico</italic>
###xml 434 441 434 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 549 556 549 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 666 667 666 667 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 687 688 687 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 853 854 853 854 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In this study, we tested the hypothesis that miR-21, an 'oncomiR', is regulated by E2 in MCF-7 breast cancer cells. Although E2 increases proliferation of MCF-7 cells, we found that E2 inhibits miR-21 expression. Experiments were performed to test the effect of E2 on targets of miR-21. In silico analysis identified miR-21 seed elements in six target genes and these miRNA recognition elements (MREs) were cloned into the 3'UTR of a Renilla reporter for subsequent transcriptional evaluation and examination of the effect of antisense to miR-21 on Renilla luciferase. Antisense to miR-21 was used to confirm the importance of miR-21-MRE interaction in response to E2. Importantly, the E2-mediated decrease in miR-21 correlated with increased expression of miR-21-targets PDCD4, PTEN and Bcl-2 at the protein level. These results identify miR-21 as an E2-ER- regulated miRNA in MCF-7 cells.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Cells and treatments
###end title 10
###begin p 11
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 101 102 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 384 387 377 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
###xml 850 851 838 839 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1036 1037 1024 1025 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
MCF-7 cells were purchased from ATCC and maintained as previously described (44). 17beta-estradiol (E2), 4-hydroxytamoxifen (4-OHT), Actinomycin D (ActD, a transcriptional inhibitor) and cycloheximide (CHX, a protein synthesis inhibitor) were purchased from Sigma; ICI 182 780 (ICI), 4,4',4''-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT, an ERalpha-selective agonist) and 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN, an ERbeta-selective agonist) were purchased from Tocris. Prior to ligand treatment, the medium was replaced with phenol red-free IMEM supplemented with 5% dextran charcoal-stripped FBS (DCC-FBS) for 48 h (serum-starved). Where indicated, MCF-7 cells were pre-treated with 10 mug/ml ActD or 10 mug/ml CHX, for 1 h before ligand treatment. Cells were treated with ethanol (EtOH, the vehicle control) 0.01% final volume, 10 nM E2, 100 nM 4-OHT, 10 nM PPT, or 10 nM DPN, alone or in combination with 100 nM ICI for 6 h. For the indicated experiments, cells were pretreated with 100 nM ICI for 6 h prior to EtOH or E2 treatment.
###end p 11
###begin title 12
miRNA microarray
###end title 12
###begin p 13
###xml 62 63 62 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 767 768 767 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 456 461 <span type="species:ncbi:9606">human</span>
RNA was isolated from MCF-7 cells treated with EtOH or 10 nM E2 for 6 h using the mirVana miRNA Isolation Kit from Ambion (Austin, TX) and was sent to LC Sciences (Houston, TX) () where the RNA samples were labeled either with Cy3 or Cy5 and were hybridized with two identical, dual-color miRNA microarray chips (MRA-1001, LC Sciences). The array contains probes to detect mature miRNA sequences as well as pre-miRNAs in the Sanger miRNA registry (). Each human miRNA on the chip contains seven redundancies for each sequence to increase sensitivity. Microarray analysis was performed by LCS including background subtraction and data normalization to the statistical median of all detectable transcripts. Two lists of differentially expressed transcripts (based on a P-value < 0.01) from two chips were merged into one list and a statistical correlation between the two sets of data was calculated.
###end p 13
###begin title 14
Constructs of miRNA-recognition elements (MREs)
###end title 14
###begin p 15
###xml 192 195 168 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 197 200 173 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 250 257 226 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 320 325 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 330 335 306 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASA1</italic>
For MRE sequences, synthetic DNA oligonucleotides (approximately35 bp) containing the MRE sequence () and approximately5 bp adjacent sequences from each end were annealed and ligated into the NotI/XhoI sites located in the 3'UTR region of the pRL-TK Renilla luciferase reporter from Promega. Full-length (FL) 3'-UTRs of PDCD4 and RASA1 were amplified by PCR and inserted into the phRL-TK vector, similarly. All constructs were confirmed by DNA sequencing.
###end p 15
###begin title 16
Quantitative real-time PCR (Q-PCR) analysis of miRNA and mRNA expression
###end title 16
###begin p 17
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mir</italic>
###xml 265 269 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 287 293 287 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMEM49</italic>
miRNA-enriched total RNA was extracted from MCF-7 cells using the mirVana miRNA isolation kit (Ambion). Quantification of miRNAs was performed using TaqMan MicroRNA Assays (Applied Biosystems). U6 RNA was used for normalization of miRNA expression. For analysis of PTEN, PDCD4, BCL2 and TMEM49 mRNA expression, RNA was extracted using Trizol and quantitation was performed using TaqMan primers and probes from ABI using 18S for normalization. Analysis and fold change were determined using the comparative threshold cycle (Ct) method. The change in miRNA or mRNA expression was calculated as fold-change, i.e. relative to EtOH-treated (control).
###end p 17
###begin title 18
Western blot
###end title 18
###begin p 19
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
Cells were treated as indicated in individual figure and whole cell extracts (WCE) were prepared in modified RIPA buffer as described (22). Western analysis was performed and quantitated as described (19). Membranes were probed with ERalpha antibodies AER320 from NeoMarkers or HC-20 from Santa Cruz Biotechnology, ERbeta antibody H150 (Santa Cruz Biotechnology), polyclonal PDCD4 antibody from Genetex, monoclonal PTEN antibody from Cell Signaling, or monoclonal Bcl-2 antibody from Assay Designs. Membranes were stripped and re-probed for beta-actin (Sigma).
###end p 19
###begin title 20
Transient transfection
###end title 20
###begin p 21
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 259 268 259 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figures 2</xref>
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 378 385 378 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 848 856 848 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 1086 1087 1086 1087 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1243 1250 1243 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1332 1340 1332 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1342 1349 1342 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1442 1450 1442 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1490 1497 1490 1497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 732 737 <span type="species:ncbi:9606">human</span>
MCF-7 cells were plated in 24-well plates at a density of 1.5 x 104 cells/well in phenol red-free OPTI-MEM I reduced serum medium (GIBCO/Invitrogen) supplemented with 10% DCC-FBS. Transient transfection was performed using FuGene6 (Roche). For experiments in Figures 2 and 3A, each well received 10 ng of pGL3-pro-luciferase reporter (Promega) as a control and 10 ng of pRL-TK, Renilla luciferase reporter (Promega) containing the indicated MRE or 3'-UTR of miR-21 target genes. For some experiments, cells were also co-transfected with 2'-O-Me-anti-miR-21 [antisense (AS)-miR-21] and the control used was the negative control #1 from Ambion: a random-sequence 2'-O-Me modified RNA molecule that has been extensively tested in many human cell lines and tissues and validated to not produce any identifiable effect on known miRNA function (23). For Figure 3A, MCF-7 cells were transfected with 250 ng of pmiR-21s-luc or pmiR-21as-luc reporters described in (45) and 5 ng pRL-TK (control). Twenty-four hours after transfection, triplicate wells were treated with EtOH (vehicle control), E2, 4-OHT or ICI 182 780 as indicated in the figure legend. The cells were harvested 30 h post-treatment using Promega's Passive Lysis buffer. Luciferase and Renilla luciferase activities were determined using Promega's Dual Luciferase assay. For Figure 2, Renilla luciferase was normalized by Firefly luciferase to correct for transfection efficiency. For Figure 3A, Firefly luciferase was normalized to Renilla luciferase. Fold induction was determined by dividing the averaged normalized values from each treatment by the EtOH value for each transfection condition within that experiment. Values were averaged from multiple experiments as indicated in the figure legends.
###end p 21
###begin title 22
AS-control and AS-miR-21 transfection
###end title 22
###begin p 23
###xml 363 364 363 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
MCF-7 cells were transfected with AS- duplexes and control-nonspecific siRNA obtained from Ambion using Lipofectamine RNAiMAX from Invitrogen according to the manufacturer's protocol. Twenty-four hours post-transfection, the medium was replaced with phenol red-free IMEM with 5% DCC for 48 h and the cells were treated with ethanol (EtOH) vehicle control, 10 nM E2, 10 nM PPT or 10 nM DPN for 24 h prior. Total RNA was isolated for Q-PCR analysis and WCEs were prepared and stored for 24 h at -80degreesC until western blot analysis. Each experiment was repeated for a total of three biological replicates. Western blots were quantified as above and the ratio of each protein/beta-actin in the AS-control in EtOH-treated samples was set to 1 in each experiment.
###end p 23
###begin title 24
ERalpha and ERbeta knockdown by siRNA
###end title 24
###begin p 25
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 191 192 191 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
MCF-7 cells were transfected with siRNA duplexes and control-nonspecific siRNA obtained from New England Biolabs (44). Forty-eight hours post-transfection, the cells were treated with 10 nM E2, 10 nM PPT or 10 nM DPN for 6 h for mRNA analysis, or 24 h for protein analysis. Total RNA was isolated for Q-PCR analysis and WCEs were prepared and stored for 24 h at -80degreesC until western blot analysis.
###end p 25
###begin title 26
Statistics
###end title 26
###begin p 27
###xml 52 53 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Statistical analyses were performed using Student's t-test or one-way ANOVA followed by Student-Newman-Keuls or Dunnett's post-hoc tests using GraphPad Prism (San Diego, CA).
###end p 27
###begin title 28
RESULTS
###end title 28
###begin title 29
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
E2 regulates miR-21 expression in MCF-7 breast cancer cells
###end title 29
###begin p 30
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 245 246 245 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 388 389 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 436 437 432 433 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 605 607 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 647 648 639 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 811 812 791 792 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 814 822 794 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 862 863 842 843 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 992 994 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 995 997 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 1093 1094 1073 1074 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1152 1153 1132 1133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1391 1392 1371 1372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1591 1599 1555 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1657 1658 1621 1622 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1740 1741 1704 1705 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1796 1805 1760 1769 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 1806 1807 1770 1771 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1932 1933 1896 1897 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2228 2229 2185 2186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2508 2509 2463 2464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2550 2551 2505 2506 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2553 2554 2508 2509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1805 2562 1769 2517 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="31">E<sub>2</sub> inhibits miR-21 expression. Summary of Q-PCR data on (mature) miR-21 expression. MCF-7 cells were treated with EtOH, 10 nM E<sub>2</sub>, 10 nM PPT (ER&#945;-selective), or 10 nM DPN (ER&#946;-selective) for 6 h. as indicated by the different fills. Where indicated MCF-7 cells were pretreated with 100 nM ICI 182 780 [ICI, an ER antagonist termed a &#8216;selective ER disrupter&#8217; (SERD)] or 100 nM 4-OHT for 6 h and then ethanol or 10 nM E<sub>2</sub> was added for an additional 6 h. Values are fold increase compared to EtOH for each miRNA and were calculated as described in &#8216;Materials and Methods&#8217; section. Values are the average of three to eight separate experiments &#177; SEM. *Significantly different from the EtOH control, <italic>P</italic> &lt; 0.05. **Significantly different from E<sub>2</sub>, <italic>P</italic> &lt; 0.05.</p>
###xml 1805 2562 1769 2517 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="31">E<sub>2</sub> inhibits miR-21 expression. Summary of Q-PCR data on (mature) miR-21 expression. MCF-7 cells were treated with EtOH, 10 nM E<sub>2</sub>, 10 nM PPT (ER&#945;-selective), or 10 nM DPN (ER&#946;-selective) for 6 h. as indicated by the different fills. Where indicated MCF-7 cells were pretreated with 100 nM ICI 182 780 [ICI, an ER antagonist termed a &#8216;selective ER disrupter&#8217; (SERD)] or 100 nM 4-OHT for 6 h and then ethanol or 10 nM E<sub>2</sub> was added for an additional 6 h. Values are fold increase compared to EtOH for each miRNA and were calculated as described in &#8216;Materials and Methods&#8217; section. Values are the average of three to eight separate experiments &#177; SEM. *Significantly different from the EtOH control, <italic>P</italic> &lt; 0.05. **Significantly different from E<sub>2</sub>, <italic>P</italic> &lt; 0.05.</p></caption>
###xml 2562 2562 2517 2517 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp117f1"/>
###xml 1796 2562 1760 2517 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="31">E<sub>2</sub> inhibits miR-21 expression. Summary of Q-PCR data on (mature) miR-21 expression. MCF-7 cells were treated with EtOH, 10 nM E<sub>2</sub>, 10 nM PPT (ER&#945;-selective), or 10 nM DPN (ER&#946;-selective) for 6 h. as indicated by the different fills. Where indicated MCF-7 cells were pretreated with 100 nM ICI 182 780 [ICI, an ER antagonist termed a &#8216;selective ER disrupter&#8217; (SERD)] or 100 nM 4-OHT for 6 h and then ethanol or 10 nM E<sub>2</sub> was added for an additional 6 h. Values are fold increase compared to EtOH for each miRNA and were calculated as described in &#8216;Materials and Methods&#8217; section. Values are the average of three to eight separate experiments &#177; SEM. *Significantly different from the EtOH control, <italic>P</italic> &lt; 0.05. **Significantly different from E<sub>2</sub>, <italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkp117f1"/></fig>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 337 342 <span type="species:ncbi:9606">human</span>
Estrogens promote breast tumor development by increasing transcription of protooncogenes and growth factors (46) and by negatively modulating the expression or functional activity of tumor suppressors (47). To determine the identity of primary E2-regulated miRNAs in estrogen-responsive human breast cancer cells, ERalpha-positive MCF-7 human breast cancer cells were treated with 10 nM E2 or EtOH (vehicle control) for 6 h. Among the E2-down-regulated miRNAs, we selected miR-21 for further evaluation because miR-21 is an oncomiR and its expression is higher in ERalpha positive versus negative tumors (40). Furthermore, no one has examined if E2 regulates miR-21 expression in breast cancer cells. Q-PCR using the TaqMan primer/probe sets from ABI indicated a approximately60% reduction in mature miR-21 by E2 (Figure 1). To determine the mechanism by which E2 reduces miR-21, MCF-7 cells were pre-incubated with 100 nM ICI 182 780 (ICI, Faslodex), a pure antagonist of ER genomic action (48,49), or 100 nM 4-OHT, the active metabolite of the antiestrogen tamoxifen, and then treated with E2. The effect of 4-OHT or ICI alone was also examined. If E2 represses miR-21 expression by binding ER, then ICI should block the decrease. Because 4-OHT has mixed ER agonist/antagonist activity in a gene- and cell-specific manner, its effect on miR-21 expression could either mimic or oppose the E2 effect, reflecting its selective ER modulator (SERM) agonist/antagonist activity. ICI reduced ERalpha protein by approximately30-50% in MCF-7 cells (), but had no effect on basal miR-21 expression (Figure 1). 4-OHT increased miR-21, indicating that 4-OHT opposes E2-induced miR-21 repression through ER binding. Since both 4-OHT and ICI relieved E2 suppression of miR-21, this reduction is ER-mediated. Figure 1.E2 inhibits miR-21 expression. Summary of Q-PCR data on (mature) miR-21 expression. MCF-7 cells were treated with EtOH, 10 nM E2, 10 nM PPT (ERalpha-selective), or 10 nM DPN (ERbeta-selective) for 6 h. as indicated by the different fills. Where indicated MCF-7 cells were pretreated with 100 nM ICI 182 780 [ICI, an ER antagonist termed a 'selective ER disrupter' (SERD)] or 100 nM 4-OHT for 6 h and then ethanol or 10 nM E2 was added for an additional 6 h. Values are fold increase compared to EtOH for each miRNA and were calculated as described in 'Materials and Methods' section. Values are the average of three to eight separate experiments +/- SEM. *Significantly different from the EtOH control, P < 0.05. **Significantly different from E2, P < 0.05.
###end p 30
###begin p 31
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 127 128 127 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 423 424 416 417 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 703 704 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 745 746 736 737 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 748 749 739 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
E2 inhibits miR-21 expression. Summary of Q-PCR data on (mature) miR-21 expression. MCF-7 cells were treated with EtOH, 10 nM E2, 10 nM PPT (ERalpha-selective), or 10 nM DPN (ERbeta-selective) for 6 h. as indicated by the different fills. Where indicated MCF-7 cells were pretreated with 100 nM ICI 182 780 [ICI, an ER antagonist termed a 'selective ER disrupter' (SERD)] or 100 nM 4-OHT for 6 h and then ethanol or 10 nM E2 was added for an additional 6 h. Values are fold increase compared to EtOH for each miRNA and were calculated as described in 'Materials and Methods' section. Values are the average of three to eight separate experiments +/- SEM. *Significantly different from the EtOH control, P < 0.05. **Significantly different from E2, P < 0.05.
###end p 31
###begin p 32
###xml 98 100 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 162 163 148 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 335 337 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 359 360 338 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 378 386 357 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 390 391 369 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 539 540 511 512 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 588 593 560 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51 B52 B53 B54">51&#8211;54</xref>
###xml 691 692 656 657 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Although ERalpha expression is higher than ERbeta in MCF-7 cells, both ER subtypes are expressed (44). To examine the contributions of ERalpha and ERbeta to the E2-induced reduction in miR-21, MCF-7 cells were treated with 10 nM PPT or 10 nM DPN, concentrations at which each is an ERalpha- or ERbeta- selective agonist, respectively (50). PPT and DPN, like E2, reduced miR-21 (Figure 1). E2 did not regulate miR-21 expression in ERalpha+/ERbeta+ T47D cells (), indicating cell-line-specific differences, similar to previous reports that E2 responses differ between MCF-7 and T47D cells (51-54). Together, these data indicate that both ERalpha and ERbeta contribute to miR-21 repression by E2.
###end p 32
###begin title 33
###xml 11 12 11 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Effect of E2 on miR-21 target gene reporter activity in MCF-7 cells
###end title 33
###begin p 34
###xml 457 464 445 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 647 648 635 636 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 650 658 638 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 672 673 660 661 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 739 746 727 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 819 827 807 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 841 842 829 830 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 888 895 876 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 966 973 951 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(TGFB1)</italic>
###xml 1000 1006 985 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4)</italic>
###xml 1037 1043 1022 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASA1)</italic>
###xml 1091 1099 1076 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASGRP1)</italic>
###xml 1173 1174 1158 1159 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1190 1191 1175 1176 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1297 1302 1282 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1)</italic>
###xml 1343 1349 1328 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB6C)</italic>
###xml 1362 1363 1347 1348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1404 1412 1389 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1495 1500 1480 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 1502 1507 1487 1492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 1509 1514 1494 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASA1</italic>
###xml 1519 1526 1504 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASGRP1</italic>
###xml 1670 1677 1655 1662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1746 1753 1731 1738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1768 1772 1753 1757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 1777 1782 1762 1767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB6C</italic>
###xml 1854 1855 1839 1840 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1938 1947 1923 1932 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 2071 2072 2056 2057 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2387 2388 2372 2373 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2390 2391 2375 2376 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2426 2427 2411 2412 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2429 2430 2414 2415 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2434 2435 2419 2420 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2511 2512 2496 2497 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2523 2530 2508 2515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 2724 2725 2707 2708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2735 2736 2718 2719 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2809 2816 2792 2799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 3182 3183 3163 3164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 3193 3194 3174 3175 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 3380 3381 3361 3362 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 3719 3720 3698 3699 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 3763 3764 3742 3743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 3773 3774 3752 3753 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 3834 3835 3813 3814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1947 3843 1932 3822 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="35">Luciferase reporter assay of putative miR-21 target genes and the effect of antisense (AS) to miR-21 on reporter activity. (<bold>A</bold>) Model of transient transfection assays in MCF-7 cells. MCF-7 cells were transiently transfected with pGL3-pro-luciferase and pRL-TK parental or pRL-TK containing putative miR-21 MREs from target genes (<ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkp117/DC1">Supplementary Table 1</ext-link>) cloned in the 3&#8242;UTR as described in &#8216;Materials and methods&#8217; section. Expected results are indicated without E<sub>2</sub> (<bold>A</bold>) and when cells are treated with E<sub>2</sub> (<bold>B</bold>). (<bold>C</bold>) MCF-7 cells were transfected as indicated and treated with EtOH or 10 nM E<sub>2</sub> for 24 h. <italic>Renilla</italic> luciferase was normalized by firefly luciferase to correct for transfection efficiency. Values are the average &#177; SEM of triplicate determinations. *Significantly different from EtOH control, <italic>P</italic> &lt; 0.01. (<bold>D</bold>) MCF-7 cells were transfected with 2&#8242;-O-Me-antisense-miR-21 (ASmiR-21). <italic>Renilla</italic> luciferase reporter gene expression from the indicated gene MREs was determined and data analyzed as described in &#8216;Materials and Methods&#8217; section. The control was a random-sequence 2&#8242;-O-Me modified RNA (control AS) as described in Materials and methods section. Values are the average &#177; SEM of triplicate determinations. *Significantly different from control AS, <italic>P</italic> &lt; 0.05. (<bold>E</bold>) MCF-7 cells were transfected with the pRL-tk-MREs or FL 3&#8242;-UTRs as indicated. Indicated cells were co-transfected with ASmiR-21 or a control AS. Cells were treated with EtOH or 10 nM E<sub>2</sub> as indicated for 24 h. Dual luciferase reporter assays were performed and data quantitated as described in &#8216;Materials and Methods&#8217; section. Values are the average &#177; SEM of triplicate determinations normalized to EtOH for each construct except that cells transfected with the ASmiR-21 were normalized against the control AS-EtOH value. <sup>a</sup>Significantly different from EtOH control, <italic>P</italic> &lt; 0.01. <sup>b</sup>Significantly different from control AS transfected values, <italic>P</italic> &lt; 0.01.</p>
###xml 1947 3843 1932 3822 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="35">Luciferase reporter assay of putative miR-21 target genes and the effect of antisense (AS) to miR-21 on reporter activity. (<bold>A</bold>) Model of transient transfection assays in MCF-7 cells. MCF-7 cells were transiently transfected with pGL3-pro-luciferase and pRL-TK parental or pRL-TK containing putative miR-21 MREs from target genes (<ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkp117/DC1">Supplementary Table 1</ext-link>) cloned in the 3&#8242;UTR as described in &#8216;Materials and methods&#8217; section. Expected results are indicated without E<sub>2</sub> (<bold>A</bold>) and when cells are treated with E<sub>2</sub> (<bold>B</bold>). (<bold>C</bold>) MCF-7 cells were transfected as indicated and treated with EtOH or 10 nM E<sub>2</sub> for 24 h. <italic>Renilla</italic> luciferase was normalized by firefly luciferase to correct for transfection efficiency. Values are the average &#177; SEM of triplicate determinations. *Significantly different from EtOH control, <italic>P</italic> &lt; 0.01. (<bold>D</bold>) MCF-7 cells were transfected with 2&#8242;-O-Me-antisense-miR-21 (ASmiR-21). <italic>Renilla</italic> luciferase reporter gene expression from the indicated gene MREs was determined and data analyzed as described in &#8216;Materials and Methods&#8217; section. The control was a random-sequence 2&#8242;-O-Me modified RNA (control AS) as described in Materials and methods section. Values are the average &#177; SEM of triplicate determinations. *Significantly different from control AS, <italic>P</italic> &lt; 0.05. (<bold>E</bold>) MCF-7 cells were transfected with the pRL-tk-MREs or FL 3&#8242;-UTRs as indicated. Indicated cells were co-transfected with ASmiR-21 or a control AS. Cells were treated with EtOH or 10 nM E<sub>2</sub> as indicated for 24 h. Dual luciferase reporter assays were performed and data quantitated as described in &#8216;Materials and Methods&#8217; section. Values are the average &#177; SEM of triplicate determinations normalized to EtOH for each construct except that cells transfected with the ASmiR-21 were normalized against the control AS-EtOH value. <sup>a</sup>Significantly different from EtOH control, <italic>P</italic> &lt; 0.01. <sup>b</sup>Significantly different from control AS transfected values, <italic>P</italic> &lt; 0.01.</p></caption>
###xml 3843 3843 3822 3822 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp117f2"/>
###xml 1938 3843 1923 3822 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="35">Luciferase reporter assay of putative miR-21 target genes and the effect of antisense (AS) to miR-21 on reporter activity. (<bold>A</bold>) Model of transient transfection assays in MCF-7 cells. MCF-7 cells were transiently transfected with pGL3-pro-luciferase and pRL-TK parental or pRL-TK containing putative miR-21 MREs from target genes (<ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkp117/DC1">Supplementary Table 1</ext-link>) cloned in the 3&#8242;UTR as described in &#8216;Materials and methods&#8217; section. Expected results are indicated without E<sub>2</sub> (<bold>A</bold>) and when cells are treated with E<sub>2</sub> (<bold>B</bold>). (<bold>C</bold>) MCF-7 cells were transfected as indicated and treated with EtOH or 10 nM E<sub>2</sub> for 24 h. <italic>Renilla</italic> luciferase was normalized by firefly luciferase to correct for transfection efficiency. Values are the average &#177; SEM of triplicate determinations. *Significantly different from EtOH control, <italic>P</italic> &lt; 0.01. (<bold>D</bold>) MCF-7 cells were transfected with 2&#8242;-O-Me-antisense-miR-21 (ASmiR-21). <italic>Renilla</italic> luciferase reporter gene expression from the indicated gene MREs was determined and data analyzed as described in &#8216;Materials and Methods&#8217; section. The control was a random-sequence 2&#8242;-O-Me modified RNA (control AS) as described in Materials and methods section. Values are the average &#177; SEM of triplicate determinations. *Significantly different from control AS, <italic>P</italic> &lt; 0.05. (<bold>E</bold>) MCF-7 cells were transfected with the pRL-tk-MREs or FL 3&#8242;-UTRs as indicated. Indicated cells were co-transfected with ASmiR-21 or a control AS. Cells were treated with EtOH or 10 nM E<sub>2</sub> as indicated for 24 h. Dual luciferase reporter assays were performed and data quantitated as described in &#8216;Materials and Methods&#8217; section. Values are the average &#177; SEM of triplicate determinations normalized to EtOH for each construct except that cells transfected with the ASmiR-21 were normalized against the control AS-EtOH value. <sup>a</sup>Significantly different from EtOH control, <italic>P</italic> &lt; 0.01. <sup>b</sup>Significantly different from control AS transfected values, <italic>P</italic> &lt; 0.01.</p></caption><graphic xlink:href="gkp117f2"/></fig>
The biological activity of miRNAs is primarily mediated by interaction with matching recognition sequences in the 3' UTRs of target genes and reducing translation. A approximately33-bp region from the 3'UTR centering on the putative miR-21 miRNA regulatory element (miRNA recognition elements (MREs), also called a 'seed element', 5'-ATAAGCTA-3'), and minimally 4 bp flanking this sequence from the six genes listed in  were cloned into the 3'UTR of pRL-TK Renilla reporter plasmid. The pRL-TK-MRE or pRL-TK parental plasmids were transiently transfected into MCF-7 cells with pGL3-pro-luciferase as a control and cells were treated with EtOH or E2 (Figure 2A and B). If E2 reduces miR-21, we would expect an increase in the expression of Renilla but not Firefly luciferase activity since repression would be relieved. Figure 2C shows that E2 specifically increased the expression of the Renilla luciferase protein from the pRL-TK- transforming growth factor beta 1 (TGFB1), Programmed Cell Death 4 (PDCD4), RAS p21 Protein Activator 1 (RASA1) and RAS Guanyl Nucleotide-Releasing Protein 1 (RASGRP1) reporters in MCF-7 cells, data consistent with miR-21 downregulation by E2. In contrast, E2 did not alter luciferase expression from the putative miR-21 MREs in Cerebral Cavernous Malformations 1 (CCM1) or a member of the RAS oncogene family (RAB6C). Thus, the E2-mediated decrease in miR-21 expression (Figure 1) resulted in lower amounts of miR-21 available to bind the MRE sequences from the TGFB1, PDCD4, RASA1 and RASGRP1 genes, in turn reducing the targeting of these reporter transcripts for degradation/translational inhibition and thus increasing the amount of Renilla protein and luciferase activity. In contrast, the lack of change in Renilla activity from CCM1 and RAB6C indicates that the MREs in these genes do not appear to be targets of E2-induced reduction of miR-21 expression in MCF-7 cells under our assay conditions. Figure 2.Luciferase reporter assay of putative miR-21 target genes and the effect of antisense (AS) to miR-21 on reporter activity. (A) Model of transient transfection assays in MCF-7 cells. MCF-7 cells were transiently transfected with pGL3-pro-luciferase and pRL-TK parental or pRL-TK containing putative miR-21 MREs from target genes () cloned in the 3'UTR as described in 'Materials and methods' section. Expected results are indicated without E2 (A) and when cells are treated with E2 (B). (C) MCF-7 cells were transfected as indicated and treated with EtOH or 10 nM E2 for 24 h. Renilla luciferase was normalized by firefly luciferase to correct for transfection efficiency. Values are the average +/- SEM of triplicate determinations. *Significantly different from EtOH control, P < 0.01. (D) MCF-7 cells were transfected with 2'-O-Me-antisense-miR-21 (ASmiR-21). Renilla luciferase reporter gene expression from the indicated gene MREs was determined and data analyzed as described in 'Materials and Methods' section. The control was a random-sequence 2'-O-Me modified RNA (control AS) as described in Materials and methods section. Values are the average +/- SEM of triplicate determinations. *Significantly different from control AS, P < 0.05. (E) MCF-7 cells were transfected with the pRL-tk-MREs or FL 3'-UTRs as indicated. Indicated cells were co-transfected with ASmiR-21 or a control AS. Cells were treated with EtOH or 10 nM E2 as indicated for 24 h. Dual luciferase reporter assays were performed and data quantitated as described in 'Materials and Methods' section. Values are the average +/- SEM of triplicate determinations normalized to EtOH for each construct except that cells transfected with the ASmiR-21 were normalized against the control AS-EtOH value. aSignificantly different from EtOH control, P < 0.01. bSignificantly different from control AS transfected values, P < 0.01.
###end p 34
###begin p 35
###xml 124 125 124 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 440 441 440 441 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 443 444 443 444 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 479 480 479 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 482 483 482 483 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 487 488 487 488 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 564 565 564 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 576 583 576 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 777 778 775 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 788 789 786 787 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 862 869 860 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1235 1236 1231 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1246 1247 1242 1243 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1433 1434 1429 1430 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1772 1773 1766 1767 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 1816 1817 1810 1811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1826 1827 1820 1821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 1887 1888 1881 1882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Luciferase reporter assay of putative miR-21 target genes and the effect of antisense (AS) to miR-21 on reporter activity. (A) Model of transient transfection assays in MCF-7 cells. MCF-7 cells were transiently transfected with pGL3-pro-luciferase and pRL-TK parental or pRL-TK containing putative miR-21 MREs from target genes () cloned in the 3'UTR as described in 'Materials and methods' section. Expected results are indicated without E2 (A) and when cells are treated with E2 (B). (C) MCF-7 cells were transfected as indicated and treated with EtOH or 10 nM E2 for 24 h. Renilla luciferase was normalized by firefly luciferase to correct for transfection efficiency. Values are the average +/- SEM of triplicate determinations. *Significantly different from EtOH control, P < 0.01. (D) MCF-7 cells were transfected with 2'-O-Me-antisense-miR-21 (ASmiR-21). Renilla luciferase reporter gene expression from the indicated gene MREs was determined and data analyzed as described in 'Materials and Methods' section. The control was a random-sequence 2'-O-Me modified RNA (control AS) as described in Materials and methods section. Values are the average +/- SEM of triplicate determinations. *Significantly different from control AS, P < 0.05. (E) MCF-7 cells were transfected with the pRL-tk-MREs or FL 3'-UTRs as indicated. Indicated cells were co-transfected with ASmiR-21 or a control AS. Cells were treated with EtOH or 10 nM E2 as indicated for 24 h. Dual luciferase reporter assays were performed and data quantitated as described in 'Materials and Methods' section. Values are the average +/- SEM of triplicate determinations normalized to EtOH for each construct except that cells transfected with the ASmiR-21 were normalized against the control AS-EtOH value. aSignificantly different from EtOH control, P < 0.01. bSignificantly different from control AS transfected values, P < 0.01.
###end p 35
###begin title 36
Effect of antisense to miR-21 target gene reporter activity in MCF-7 cells
###end title 36
###begin p 37
###xml 8 9 8 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 30 37 30 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASA1</italic>
###xml 94 101 94 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASGRP1</italic>
###xml 116 124 116 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 334 335 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 364 372 364 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 427 435 427 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 487 494 487 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 559 564 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 566 571 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 573 578 573 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASA1</italic>
###xml 583 590 583 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASGRP1</italic>
###xml 689 693 689 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCM1</italic>
###xml 697 702 697 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB6C</italic>
###xml 704 712 704 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 754 755 754 755 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 767 775 767 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 789 790 789 790 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 824 829 824 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASA1</italic>
If the E2-induced increase in Renilla luciferase from the MREs of the TGFB1, PDCD4, RASA1 and RASGRP1 genes seen in Figure 2C is due to reduced levels of endogenous miR-21, then transfection of MCF-7 cells with antisense (AS)-miR-21 should have the same effect on luciferase activity. MCF-7 cells were transiently transfected with 2'-O-Me-anti-miR-21 (AS-miR-21) (Figure 2D). A 92% knockdown of miR-21 expression was achieved (Figure 5A). AS-miR-21 resulted in a significant increase in Renilla activity from pRL-TK reporters bearing the miR-21 MREs from the TGFB1, PDCD4, RASA1 and RASGRP1 genes. In contrast, AS-miR-21 did not affect luciferase activity from the putative miR-21 MREs in CCM1 or RAB6C (Figure 2D). These data are in agreement with the E2 responses (Figure 2C), although E2 induced higher activity from the RASA1 reporter compared to the ASmiR-21. Overall, these data indicate that these MREs are bone fide targets of miR-21 regulation.
###end p 37
###begin title 38
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASA1</italic>
MRE and FL 3'-UTRs activities of PDCD4 and RASA1 in reporter assays in MCF-7 cells
###end title 38
###begin p 39
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 115 116 115 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 183 188 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASA1</italic>
###xml 206 214 206 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 219 220 219 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 357 362 357 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 458 463 458 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASA1</italic>
###xml 515 516 515 516 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 546 551 546 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 556 561 556 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASA1</italic>
###xml 620 621 620 621 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Since sequences flanking the MRE affect miRNA binding and activity (55), it is important to compare the effect of E2 and AS-miR-21 in reporters bearing the MRE versus the FL 3'UTR of PDCD4 and RASA1 genes (Figure 2E). E2 induced greater luciferase activity from the FL than the PDCD4 MRE. AS-miR-21 increased reporter activity more from the MRE than the FL PDCD4. The AS-miR-21-induced increase in basal luciferase activity was comparable for the MRE and FL RASA1 reporters. AS-mR-21 transfection reduced the fold E2-induction for the MRE and FL PDCD4 and RASA1 reporters. The miR-21 knockdown data are consistent with E2-ER downregulation of miR-21 increasing reporter activity.
###end p 39
###begin title 40
###xml 57 58 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Regulation of primary (pri)-miR-21 promoter activity by E2, 4-OHT and ICI 182,780 in MCF-7 cells
###end title 40
###begin p 41
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMEM49</italic>
###xml 57 59 57 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 79 80 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 221 223 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 469 471 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 474 482 450 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 646 647 610 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 784 785 748 749 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 893 901 833 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 938 939 878 879 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1012 1013 952 953 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1028 1034 968 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMEM49</italic>
###xml 1050 1058 990 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1128 1129 1068 1069 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1133 1139 1073 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMEM49</italic>
###xml 1216 1222 1156 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMEM49</italic>
###xml 1250 1252 1190 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 1384 1385 1324 1325 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1417 1425 1357 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1540 1541 1480 1481 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1543 1552 1483 1492 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 1604 1605 1544 1545 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1619 1620 1559 1560 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1880 1882 1820 1822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 1888 1895 1828 1835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1988 1989 1928 1929 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2091 2098 2031 2038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 2281 2282 2219 2220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2335 2336 2273 2274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2384 2385 2322 2323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2387 2388 2325 2326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2398 2399 2336 2337 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2402 2403 2340 2341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2420 2426 2358 2364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMEM49</italic>
###xml 2505 2511 2443 2449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMEM49</italic>
###xml 2518 2520 2456 2458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 2568 2569 2506 2507 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2638 2644 2576 2582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMEM49</italic>
###xml 2749 2750 2685 2686 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2757 2758 2693 2694 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 3075 3076 3010 3011 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1552 3348 1492 3283 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="42">Regulation of miR-21 transcription in MCF-7 cells. (<bold>A</bold>) Effects of E<sub>2</sub>, 4-OHT and ICI 182 780 (ICI) on the primary miR-21 (pri-miR-21) gene promoter in the sense (pmiR-21s-luc) or antisense (as) pmiR-21as-luc orientation. MCF-7 cells were transfected with pri-miR-21s-luc or pri-miR-21as-luc (hatched bars, values were very low) (<xref ref-type="bibr" rid="B45">45</xref>) and <italic>Renilla</italic> luciferase as an internal control. Cells were treated with the indicated concentrations of E<sub>2</sub>, 4-OHT, or ICI for 24 h. Dual luciferase assays were performed and luciferase values were divided by <italic>Renilla</italic> values in the same sample. Values are the average &#177; SEM of triplicate determinations normalized to EtOH for the pmiR-21s-luc construct. *Significantly different from EtOH control, <italic>P</italic> &lt; 0.05. **Significantly different from 4-OHT alone, <italic>P</italic> &lt; 0.05. ***Significantly different from 10 nM E<sub>2</sub>, <italic>P</italic> &lt; 0.05. (<bold>B</bold>) E<sub>2</sub> does not affect <italic>TMEM49</italic> transcription in MCF-7 cells. miR-21 is encoded within the 10th intron of the <italic>TMEM49</italic> gene (<xref ref-type="bibr" rid="B56">56</xref>). MCF-7 cells were treated with EtOH or 10 nM E<sub>2</sub> for 6 h, total RNA was reverse transcribed and Q&#8211;PCR was performed. <italic>TMEM49</italic> was normalized to 18S. Values are the average &#177; SEM of triplicate determinations normalized to EtOH. (<bold>C</bold>) The E<sub>2</sub>-induced decrease in miR-21 expression in MCF-7 cells is mediated in a primary transcriptional/genomic and secondary estrogen-target-dependent manner. MCF-7 cells were pre-treated with stripped medium or stripped medium containing 10 &#956;g/ml ActD or CHX for 1 h before treatment with vehicle control (EtOH), or 10 nM E<sub>2</sub> for 6 h as described in &#8216;Materials and Methods&#8217; section. miR-21 expression was determined using Q-PCR as described in &#8216;Materials and Methods&#8217; section. The bar graph summarizes the fold change in miR-21 expression relative to no pretreatment (No pretx)-EtOH-treated cells.</p>
###xml 1552 3348 1492 3283 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="42">Regulation of miR-21 transcription in MCF-7 cells. (<bold>A</bold>) Effects of E<sub>2</sub>, 4-OHT and ICI 182 780 (ICI) on the primary miR-21 (pri-miR-21) gene promoter in the sense (pmiR-21s-luc) or antisense (as) pmiR-21as-luc orientation. MCF-7 cells were transfected with pri-miR-21s-luc or pri-miR-21as-luc (hatched bars, values were very low) (<xref ref-type="bibr" rid="B45">45</xref>) and <italic>Renilla</italic> luciferase as an internal control. Cells were treated with the indicated concentrations of E<sub>2</sub>, 4-OHT, or ICI for 24 h. Dual luciferase assays were performed and luciferase values were divided by <italic>Renilla</italic> values in the same sample. Values are the average &#177; SEM of triplicate determinations normalized to EtOH for the pmiR-21s-luc construct. *Significantly different from EtOH control, <italic>P</italic> &lt; 0.05. **Significantly different from 4-OHT alone, <italic>P</italic> &lt; 0.05. ***Significantly different from 10 nM E<sub>2</sub>, <italic>P</italic> &lt; 0.05. (<bold>B</bold>) E<sub>2</sub> does not affect <italic>TMEM49</italic> transcription in MCF-7 cells. miR-21 is encoded within the 10th intron of the <italic>TMEM49</italic> gene (<xref ref-type="bibr" rid="B56">56</xref>). MCF-7 cells were treated with EtOH or 10 nM E<sub>2</sub> for 6 h, total RNA was reverse transcribed and Q&#8211;PCR was performed. <italic>TMEM49</italic> was normalized to 18S. Values are the average &#177; SEM of triplicate determinations normalized to EtOH. (<bold>C</bold>) The E<sub>2</sub>-induced decrease in miR-21 expression in MCF-7 cells is mediated in a primary transcriptional/genomic and secondary estrogen-target-dependent manner. MCF-7 cells were pre-treated with stripped medium or stripped medium containing 10 &#956;g/ml ActD or CHX for 1 h before treatment with vehicle control (EtOH), or 10 nM E<sub>2</sub> for 6 h as described in &#8216;Materials and Methods&#8217; section. miR-21 expression was determined using Q-PCR as described in &#8216;Materials and Methods&#8217; section. The bar graph summarizes the fold change in miR-21 expression relative to no pretreatment (No pretx)-EtOH-treated cells.</p></caption>
###xml 3348 3348 3283 3283 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp117f3"/>
###xml 1543 3348 1483 3283 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="42">Regulation of miR-21 transcription in MCF-7 cells. (<bold>A</bold>) Effects of E<sub>2</sub>, 4-OHT and ICI 182 780 (ICI) on the primary miR-21 (pri-miR-21) gene promoter in the sense (pmiR-21s-luc) or antisense (as) pmiR-21as-luc orientation. MCF-7 cells were transfected with pri-miR-21s-luc or pri-miR-21as-luc (hatched bars, values were very low) (<xref ref-type="bibr" rid="B45">45</xref>) and <italic>Renilla</italic> luciferase as an internal control. Cells were treated with the indicated concentrations of E<sub>2</sub>, 4-OHT, or ICI for 24 h. Dual luciferase assays were performed and luciferase values were divided by <italic>Renilla</italic> values in the same sample. Values are the average &#177; SEM of triplicate determinations normalized to EtOH for the pmiR-21s-luc construct. *Significantly different from EtOH control, <italic>P</italic> &lt; 0.05. **Significantly different from 4-OHT alone, <italic>P</italic> &lt; 0.05. ***Significantly different from 10 nM E<sub>2</sub>, <italic>P</italic> &lt; 0.05. (<bold>B</bold>) E<sub>2</sub> does not affect <italic>TMEM49</italic> transcription in MCF-7 cells. miR-21 is encoded within the 10th intron of the <italic>TMEM49</italic> gene (<xref ref-type="bibr" rid="B56">56</xref>). MCF-7 cells were treated with EtOH or 10 nM E<sub>2</sub> for 6 h, total RNA was reverse transcribed and Q&#8211;PCR was performed. <italic>TMEM49</italic> was normalized to 18S. Values are the average &#177; SEM of triplicate determinations normalized to EtOH. (<bold>C</bold>) The E<sub>2</sub>-induced decrease in miR-21 expression in MCF-7 cells is mediated in a primary transcriptional/genomic and secondary estrogen-target-dependent manner. MCF-7 cells were pre-treated with stripped medium or stripped medium containing 10 &#956;g/ml ActD or CHX for 1 h before treatment with vehicle control (EtOH), or 10 nM E<sub>2</sub> for 6 h as described in &#8216;Materials and Methods&#8217; section. miR-21 expression was determined using Q-PCR as described in &#8216;Materials and Methods&#8217; section. The bar graph summarizes the fold change in miR-21 expression relative to no pretreatment (No pretx)-EtOH-treated cells.</p></caption><graphic xlink:href="gkp117f3"/></fig>
miR-21 is located in the 10th intron of the TMEM49 gene (56). To test whether E2 regulates miR-21 gene expression through the approximately-1 kb 5'flanking region previously reported to function as a promoter for miR-21 (45), transient transfection assays were performed using two constructs: pmiR-21s-luc and pmiR-21as-luc, corresponding to the sense (s) and antisense (as) orientations of this approximately1 kb region cloned in front of the Firefly luciferase gene (45) (Figure 3A). The activity from the pmiR-21as-luc reporter was approximately2% of that of the pmiR-21s-luc construct, indicating orientation-dependent promoter activity. If E2 represses miR-21 expression by an interaction of ER with the 5' promoter, we should detect a decrease in luciferase reporter activity. E2 reduced luciferase activity approximately25% whereas 4-OHT increased pmiR-21 activity by approximately25% (Figure 3A). ICI abrogated the inhibition by E2, indicating that ER is responsible for reduction in reporter activity. E2 did not alter TMEM49 transcription (Figure 3B). To our knowledge, this is the first examination of the effect of E2 on TMEM49 transcription. These data are consistent with the independent regulation of TMEM49 and miR-21 in HL-60 cells (56). Overall, these data agree with the direction, although not magnitude, of changes in endogenous miR-21 expression in response to E2, 4-OHT and ICI in MCF-7 cells (Figure 1) and indicate that the -1 kb promoter of miR-21 mediates in part, the observed reduction in miR-21 expression by E2. Figure 3.Regulation of miR-21 transcription in MCF-7 cells. (A) Effects of E2, 4-OHT and ICI 182 780 (ICI) on the primary miR-21 (pri-miR-21) gene promoter in the sense (pmiR-21s-luc) or antisense (as) pmiR-21as-luc orientation. MCF-7 cells were transfected with pri-miR-21s-luc or pri-miR-21as-luc (hatched bars, values were very low) (45) and Renilla luciferase as an internal control. Cells were treated with the indicated concentrations of E2, 4-OHT, or ICI for 24 h. Dual luciferase assays were performed and luciferase values were divided by Renilla values in the same sample. Values are the average +/- SEM of triplicate determinations normalized to EtOH for the pmiR-21s-luc construct. *Significantly different from EtOH control, P < 0.05. **Significantly different from 4-OHT alone, P < 0.05. ***Significantly different from 10 nM E2, P < 0.05. (B) E2 does not affect TMEM49 transcription in MCF-7 cells. miR-21 is encoded within the 10th intron of the TMEM49 gene (56). MCF-7 cells were treated with EtOH or 10 nM E2 for 6 h, total RNA was reverse transcribed and Q-PCR was performed. TMEM49 was normalized to 18S. Values are the average +/- SEM of triplicate determinations normalized to EtOH. (C) The E2-induced decrease in miR-21 expression in MCF-7 cells is mediated in a primary transcriptional/genomic and secondary estrogen-target-dependent manner. MCF-7 cells were pre-treated with stripped medium or stripped medium containing 10 mug/ml ActD or CHX for 1 h before treatment with vehicle control (EtOH), or 10 nM E2 for 6 h as described in 'Materials and Methods' section. miR-21 expression was determined using Q-PCR as described in 'Materials and Methods' section. The bar graph summarizes the fold change in miR-21 expression relative to no pretreatment (No pretx)-EtOH-treated cells.
###end p 41
###begin p 42
###xml 52 53 52 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 67 68 67 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 336 343 336 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 436 437 436 437 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 539 546 539 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 729 730 727 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 783 784 781 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 832 833 830 831 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 835 836 833 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 846 847 844 845 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 850 851 848 849 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 868 874 866 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMEM49</italic>
###xml 953 959 951 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMEM49</italic>
###xml 966 968 964 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 1016 1017 1014 1015 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1086 1092 1084 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMEM49</italic>
###xml 1197 1198 1193 1194 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1205 1206 1201 1202 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1523 1524 1518 1519 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Regulation of miR-21 transcription in MCF-7 cells. (A) Effects of E2, 4-OHT and ICI 182 780 (ICI) on the primary miR-21 (pri-miR-21) gene promoter in the sense (pmiR-21s-luc) or antisense (as) pmiR-21as-luc orientation. MCF-7 cells were transfected with pri-miR-21s-luc or pri-miR-21as-luc (hatched bars, values were very low) (45) and Renilla luciferase as an internal control. Cells were treated with the indicated concentrations of E2, 4-OHT, or ICI for 24 h. Dual luciferase assays were performed and luciferase values were divided by Renilla values in the same sample. Values are the average +/- SEM of triplicate determinations normalized to EtOH for the pmiR-21s-luc construct. *Significantly different from EtOH control, P < 0.05. **Significantly different from 4-OHT alone, P < 0.05. ***Significantly different from 10 nM E2, P < 0.05. (B) E2 does not affect TMEM49 transcription in MCF-7 cells. miR-21 is encoded within the 10th intron of the TMEM49 gene (56). MCF-7 cells were treated with EtOH or 10 nM E2 for 6 h, total RNA was reverse transcribed and Q-PCR was performed. TMEM49 was normalized to 18S. Values are the average +/- SEM of triplicate determinations normalized to EtOH. (C) The E2-induced decrease in miR-21 expression in MCF-7 cells is mediated in a primary transcriptional/genomic and secondary estrogen-target-dependent manner. MCF-7 cells were pre-treated with stripped medium or stripped medium containing 10 mug/ml ActD or CHX for 1 h before treatment with vehicle control (EtOH), or 10 nM E2 for 6 h as described in 'Materials and Methods' section. miR-21 expression was determined using Q-PCR as described in 'Materials and Methods' section. The bar graph summarizes the fold change in miR-21 expression relative to no pretreatment (No pretx)-EtOH-treated cells.
###end p 42
###begin title 43
###xml 52 53 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Actinomycin D (ActD) and cycloheximide (CHX) block E2-mediated miR-21 expression
###end title 43
###begin p 44
###xml 26 27 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 305 306 305 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 318 326 318 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 370 371 370 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 417 418 417 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
To determine whether the E2-mediated reduction in miR-21 expression is a direct effect of ER at the genomic level or requires synthesis of a secondary estrogen-responsive protein, MCF-7 cells were pretreated with the transcriptional inhibitor ActD or the protein synthesis inhibitor CHX prior to EtOH or E2 treatment (Figure 3C). Pretreatment with ActD and CHX blocked E2-mediated miR-21 repression, indicating that E2-repression is mediated by both transcriptional (primary genomic) and secondary mechanisms.
###end p 44
###begin title 45
###xml 11 12 11 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Effect of E2, PPT and DPN on endogenous miR-21 target genes in MCF-7 cells
###end title 45
###begin p 46
###xml 7 8 7 8 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 135 136 135 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 202 207 202 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 246 254 246 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 275 283 275 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 514 516 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 568 573 561 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 577 585 570 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 588 589 581 582 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 606 614 599 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 630 638 623 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 657 662 650 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 706 714 699 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 788 792 781 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 813 818 806 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 823 827 816 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 873 878 866 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 893 897 886 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 911 919 904 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 956 964 949 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 969 970 962 963 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1027 1035 1020 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1174 1175 1160 1161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1243 1251 1229 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1253 1262 1239 1248 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 1434 1435 1420 1421 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1569 1570 1548 1549 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1622 1623 1601 1602 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1831 1832 1808 1809 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2071 2072 2045 2046 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2280 2281 2252 2253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1262 2289 1248 2261 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="47">Effect of ER ligands on endogenous miR21 target gene mRNA and protein expression in MCF-7 cells. MCF-7 cells were serum-starved for 48 h and then treated with EtOH, 10 nM E<sub>2</sub>, 10 nM PPT (ER&#945; selective), or 10 nM DPN (ER&#946; selective) for 6 h prior to RNA isolation (A) or 24 h prior to WCE preparation (<bold>B</bold>) as described in &#8216;Materials and methods&#8217; section. (<bold>A</bold>) Q-PCR was performed for the indicated genes and fold-expression determined compared to EtOH as described in &#8216;Materials and Methods&#8217; section. Values are the average of four separate determinations &#177; SEM. (<bold>B</bold>) Western blot for the indicated proteins. The membrane was stripped and reprobed for &#946;-actin for normalization as described in &#8216;Materials and Methods&#8217; section. The blot shown is representative of three separate biological replicates. (<bold>C</bold>) Western data are presented as relative to non-treated (No TX) MCF-7 cells. The values in C are the mean &#177; SEM of three separate experiments. *Significantly different from the EtOH value for each protein, <italic>P</italic> &lt; 0.01.</p>
###xml 1262 2289 1248 2261 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="47">Effect of ER ligands on endogenous miR21 target gene mRNA and protein expression in MCF-7 cells. MCF-7 cells were serum-starved for 48 h and then treated with EtOH, 10 nM E<sub>2</sub>, 10 nM PPT (ER&#945; selective), or 10 nM DPN (ER&#946; selective) for 6 h prior to RNA isolation (A) or 24 h prior to WCE preparation (<bold>B</bold>) as described in &#8216;Materials and methods&#8217; section. (<bold>A</bold>) Q-PCR was performed for the indicated genes and fold-expression determined compared to EtOH as described in &#8216;Materials and Methods&#8217; section. Values are the average of four separate determinations &#177; SEM. (<bold>B</bold>) Western blot for the indicated proteins. The membrane was stripped and reprobed for &#946;-actin for normalization as described in &#8216;Materials and Methods&#8217; section. The blot shown is representative of three separate biological replicates. (<bold>C</bold>) Western data are presented as relative to non-treated (No TX) MCF-7 cells. The values in C are the mean &#177; SEM of three separate experiments. *Significantly different from the EtOH value for each protein, <italic>P</italic> &lt; 0.01.</p></caption>
###xml 2289 2289 2261 2261 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp117f4"/>
###xml 1253 2289 1239 2261 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="47">Effect of ER ligands on endogenous miR21 target gene mRNA and protein expression in MCF-7 cells. MCF-7 cells were serum-starved for 48 h and then treated with EtOH, 10 nM E<sub>2</sub>, 10 nM PPT (ER&#945; selective), or 10 nM DPN (ER&#946; selective) for 6 h prior to RNA isolation (A) or 24 h prior to WCE preparation (<bold>B</bold>) as described in &#8216;Materials and methods&#8217; section. (<bold>A</bold>) Q-PCR was performed for the indicated genes and fold-expression determined compared to EtOH as described in &#8216;Materials and Methods&#8217; section. Values are the average of four separate determinations &#177; SEM. (<bold>B</bold>) Western blot for the indicated proteins. The membrane was stripped and reprobed for &#946;-actin for normalization as described in &#8216;Materials and Methods&#8217; section. The blot shown is representative of three separate biological replicates. (<bold>C</bold>) Western data are presented as relative to non-treated (No TX) MCF-7 cells. The values in C are the mean &#177; SEM of three separate experiments. *Significantly different from the EtOH value for each protein, <italic>P</italic> &lt; 0.01.</p></caption><graphic xlink:href="gkp117f4"/></fig>
Since E2 reduced miR-21 expression in MCF-7 cells and increased the expression of miR-21 target reporter gene activity, the effect of E2 on the mRNA and protein levels of endogenous miR-21-target genes PDCD4, PTEN and BCL2 was examined by Q-PCR (Figure 4A) and western blot (Figure 4B and C). To determine the relative contribution of the two ER subtypes to these effects, MCF-7 cells were treated with 10 nM PPT or 10 nM DPN, concentrations at which each is an ERalpha- or ERbeta-selective agonist, respectively (50). As expected based on the reporter assay data for PDCD4 in Figure 2, E2 increased mRNA (Figure 4A) and protein (Figure 4B and C) levels of PDCD4, results reflecting reduced miR-21 levels (Figure 1), thus increased transcript stability. Similar results were observed for BCL2. PPT also increased PDCD4 and BCL2 mRNA and protein levels, whereas DPN reduced PDCD4 and increased BCL2 mRNA levels (Figure 4A) while increasing protein amounts (Figure 4B). E2, PPT and DPN increased PTEN protein but not RNA levels (Figure 4A and C), suggesting translational inhibition. Overall, these data indicate roles for both ERalpha and ERbeta in mediating the effects of E2 on miR-21 target gene expression, consistent with results shown in Figure 1. Figure 4.Effect of ER ligands on endogenous miR21 target gene mRNA and protein expression in MCF-7 cells. MCF-7 cells were serum-starved for 48 h and then treated with EtOH, 10 nM E2, 10 nM PPT (ERalpha selective), or 10 nM DPN (ERbeta selective) for 6 h prior to RNA isolation (A) or 24 h prior to WCE preparation (B) as described in 'Materials and methods' section. (A) Q-PCR was performed for the indicated genes and fold-expression determined compared to EtOH as described in 'Materials and Methods' section. Values are the average of four separate determinations +/- SEM. (B) Western blot for the indicated proteins. The membrane was stripped and reprobed for beta-actin for normalization as described in 'Materials and Methods' section. The blot shown is representative of three separate biological replicates. (C) Western data are presented as relative to non-treated (No TX) MCF-7 cells. The values in C are the mean +/- SEM of three separate experiments. *Significantly different from the EtOH value for each protein, P < 0.01.
###end p 46
###begin p 47
###xml 172 173 172 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 307 308 300 301 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 360 361 353 354 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 569 570 560 561 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 809 810 797 798 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1018 1019 1004 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Effect of ER ligands on endogenous miR21 target gene mRNA and protein expression in MCF-7 cells. MCF-7 cells were serum-starved for 48 h and then treated with EtOH, 10 nM E2, 10 nM PPT (ERalpha selective), or 10 nM DPN (ERbeta selective) for 6 h prior to RNA isolation (A) or 24 h prior to WCE preparation (B) as described in 'Materials and methods' section. (A) Q-PCR was performed for the indicated genes and fold-expression determined compared to EtOH as described in 'Materials and Methods' section. Values are the average of four separate determinations +/- SEM. (B) Western blot for the indicated proteins. The membrane was stripped and reprobed for beta-actin for normalization as described in 'Materials and Methods' section. The blot shown is representative of three separate biological replicates. (C) Western data are presented as relative to non-treated (No TX) MCF-7 cells. The values in C are the mean +/- SEM of three separate experiments. *Significantly different from the EtOH value for each protein, P < 0.01.
###end p 47
###begin title 48
AS-miR-21 inhibits endogenous miR-21 target gene protein expression in MCF-7 cells
###end title 48
###begin p 49
###xml 214 215 214 215 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 414 422 414 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 509 517 509 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 607 615 607 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 705 706 705 706 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 729 738 729 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figures 4</xref>
###xml 890 891 890 891 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 967 975 967 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 979 988 979 988 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 989 990 989 990 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</bold>
###xml 1050 1051 1050 1051 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1437 1438 1435 1436 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1585 1586 1583 1584 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1915 1916 1910 1911 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2260 2261 2247 2248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 988 2269 988 2256 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="50">A<bold>S</bold>-miR-21 increases the expression of PTEN, PDCD4 and Bcl-2. (<bold>A</bold>) The specificity of AS-miR-21 to decrease miR-21was examined by Q-PCR in parallel with miR-125a and miR-30b as negative controls. MCF-7 cells were not transfected (unTF) or were transfected with AS-control or AS-miR-21 for 48 h prior to RNA harvest. Q-PCR was performed for the indicated miRs. The values are the average of three separate experiments, each run in triplicate, &#177; SD. (<bold>B</bold>) MCF-7 cells were transfected with AS-control or AS-miR-21 for 24 h prior to serum deprivation for 48 h and then 24 h treatment with EtOH, 10 nM E<sub>2</sub>, PPT or DPN, as indicated. WCE were used for western blot for the indicated proteins as described in &#8216;Materials and methods&#8217; section. The membrane was stripped and reprobed for &#946;-actin for normalization as described in Materials and Methods section. The blot shown is representative of three separate biological replicates. (<bold>C</bold>) The values graphed are the mean &#177; SEM of the normalized western data (each protein was normalized to &#946;-actin input and then the ratio of each protein/&#946;-actin in the AS-control in EtOH-treated samples was set to one in each experiment) in three separate experiments. *Significantly different from the EtOH AS-control for each protein, <italic>P</italic> &lt; 0.05.</p>
###xml 988 2269 988 2256 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="50">A<bold>S</bold>-miR-21 increases the expression of PTEN, PDCD4 and Bcl-2. (<bold>A</bold>) The specificity of AS-miR-21 to decrease miR-21was examined by Q-PCR in parallel with miR-125a and miR-30b as negative controls. MCF-7 cells were not transfected (unTF) or were transfected with AS-control or AS-miR-21 for 48 h prior to RNA harvest. Q-PCR was performed for the indicated miRs. The values are the average of three separate experiments, each run in triplicate, &#177; SD. (<bold>B</bold>) MCF-7 cells were transfected with AS-control or AS-miR-21 for 24 h prior to serum deprivation for 48 h and then 24 h treatment with EtOH, 10 nM E<sub>2</sub>, PPT or DPN, as indicated. WCE were used for western blot for the indicated proteins as described in &#8216;Materials and methods&#8217; section. The membrane was stripped and reprobed for &#946;-actin for normalization as described in Materials and Methods section. The blot shown is representative of three separate biological replicates. (<bold>C</bold>) The values graphed are the mean &#177; SEM of the normalized western data (each protein was normalized to &#946;-actin input and then the ratio of each protein/&#946;-actin in the AS-control in EtOH-treated samples was set to one in each experiment) in three separate experiments. *Significantly different from the EtOH AS-control for each protein, <italic>P</italic> &lt; 0.05.</p></caption>
###xml 2269 2269 2256 2256 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp117f5"/>
###xml 979 2269 979 2256 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="50">A<bold>S</bold>-miR-21 increases the expression of PTEN, PDCD4 and Bcl-2. (<bold>A</bold>) The specificity of AS-miR-21 to decrease miR-21was examined by Q-PCR in parallel with miR-125a and miR-30b as negative controls. MCF-7 cells were not transfected (unTF) or were transfected with AS-control or AS-miR-21 for 48 h prior to RNA harvest. Q-PCR was performed for the indicated miRs. The values are the average of three separate experiments, each run in triplicate, &#177; SD. (<bold>B</bold>) MCF-7 cells were transfected with AS-control or AS-miR-21 for 24 h prior to serum deprivation for 48 h and then 24 h treatment with EtOH, 10 nM E<sub>2</sub>, PPT or DPN, as indicated. WCE were used for western blot for the indicated proteins as described in &#8216;Materials and methods&#8217; section. The membrane was stripped and reprobed for &#946;-actin for normalization as described in Materials and Methods section. The blot shown is representative of three separate biological replicates. (<bold>C</bold>) The values graphed are the mean &#177; SEM of the normalized western data (each protein was normalized to &#946;-actin input and then the ratio of each protein/&#946;-actin in the AS-control in EtOH-treated samples was set to one in each experiment) in three separate experiments. *Significantly different from the EtOH AS-control for each protein, <italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkp117f5"/></fig>
To confirm the role of downregulation of miR-21 in the increase in protein expression of Pdcd4, PTEN and Bcl-2, MCF-7 cells were transfected with AS-control and AS-miR-21 plasmids followed by treatment with EtOH, E2, PPT and DPN for 24 h. If the ER-ligand-induced reduction in miR-21 causes an increase in target protein expression, then the AS-miR-21 should have the same effect. AS-miR-21 reduced miR-21 by 92% (Figure 5A). Specific knockdown of miR-21, and not miR-125a or miR-30b, was confirmed by Q-PCR (Figure 5A). AS-miR-21 significantly increased the basal Pdcd4, PTEN and Bcl-2 protein expression (Figure 5B and C). AS-control did not affect the observed increase in each protein in response to E2, PPT and DPN (compare Figures 4B, C and 5B, C). These data indicate that these genes are targets of repression by miR-21. No further increase in protein expression was detected with E2 or PPT treatment, but DPN significantly increased Pdcd4 and PTEN proteins (Figure 5C). Figure 5.AS-miR-21 increases the expression of PTEN, PDCD4 and Bcl-2. (A) The specificity of AS-miR-21 to decrease miR-21was examined by Q-PCR in parallel with miR-125a and miR-30b as negative controls. MCF-7 cells were not transfected (unTF) or were transfected with AS-control or AS-miR-21 for 48 h prior to RNA harvest. Q-PCR was performed for the indicated miRs. The values are the average of three separate experiments, each run in triplicate, +/- SD. (B) MCF-7 cells were transfected with AS-control or AS-miR-21 for 24 h prior to serum deprivation for 48 h and then 24 h treatment with EtOH, 10 nM E2, PPT or DPN, as indicated. WCE were used for western blot for the indicated proteins as described in 'Materials and methods' section. The membrane was stripped and reprobed for beta-actin for normalization as described in Materials and Methods section. The blot shown is representative of three separate biological replicates. (C) The values graphed are the mean +/- SEM of the normalized western data (each protein was normalized to beta-actin input and then the ratio of each protein/beta-actin in the AS-control in EtOH-treated samples was set to one in each experiment) in three separate experiments. *Significantly different from the EtOH AS-control for each protein, P < 0.05.
###end p 49
###begin p 50
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</bold>
###xml 62 63 62 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 449 450 447 448 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 597 598 595 596 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 927 928 922 923 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1272 1273 1259 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
AS-miR-21 increases the expression of PTEN, PDCD4 and Bcl-2. (A) The specificity of AS-miR-21 to decrease miR-21was examined by Q-PCR in parallel with miR-125a and miR-30b as negative controls. MCF-7 cells were not transfected (unTF) or were transfected with AS-control or AS-miR-21 for 48 h prior to RNA harvest. Q-PCR was performed for the indicated miRs. The values are the average of three separate experiments, each run in triplicate, +/- SD. (B) MCF-7 cells were transfected with AS-control or AS-miR-21 for 24 h prior to serum deprivation for 48 h and then 24 h treatment with EtOH, 10 nM E2, PPT or DPN, as indicated. WCE were used for western blot for the indicated proteins as described in 'Materials and methods' section. The membrane was stripped and reprobed for beta-actin for normalization as described in Materials and Methods section. The blot shown is representative of three separate biological replicates. (C) The values graphed are the mean +/- SEM of the normalized western data (each protein was normalized to beta-actin input and then the ratio of each protein/beta-actin in the AS-control in EtOH-treated samples was set to one in each experiment) in three separate experiments. *Significantly different from the EtOH AS-control for each protein, P < 0.05.
###end p 50
###begin title 51
###xml 33 34 29 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Effect of ERalpha knock-down on E2-induced endogenous miR-21 target gene expression in MCF-7 cells
###end title 51
###begin p 52
###xml 128 129 124 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 258 259 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 468 476 433 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 514 515 475 476 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 546 554 507 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 606 607 563 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 653 658 610 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 660 664 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 669 673 626 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 675 683 632 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 831 839 788 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 895 896 848 849 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 960 965 913 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 967 971 920 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 976 980 929 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 998 1006 951 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1168 1177 1113 1122 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 1226 1227 1164 1165 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1306 1307 1244 1245 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1714 1715 1634 1635 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1826 1827 1742 1743 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1892 1893 1808 1809 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1898 1899 1814 1815 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1919 1920 1835 1836 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1925 1926 1841 1842 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 2180 2181 2094 2095 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 2291 2292 2202 2203 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2461 2462 2368 2369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2503 2504 2410 2411 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2551 2552 2458 2459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1177 2560 1122 2467 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="53">ER&#945;, but not ER&#946;, knockdown inhibits the E<sub>2</sub>-mediated decrease in miR-21 and thus reverses miR-21 target gene expression. (<bold>A</bold>) MCF-7 cells were not transfected (Not TF) or transfected with siControl RNA or siER&#945; as described in &#8216;Materials and Methods&#8217; section for 48 h and WCE were analyzed for ER&#945; and ER&#946; by western blot as described in &#8216;Materials and Methods&#8217; section. The same membrane was stripped and reprobed for &#946;-actin for normalization. The% ER&#945; knockdown was calculated relative to the Not TF control. (<bold>B</bold>) MCF-7 cells were transfected with siControl RNA or siER&#945; for 48 h prior to treatment with EtOH or 10 nM E<sub>2</sub>, PPT, or DPN for 6 h. RNA and protein were extracted and Q-PCR (<bold>B</bold> and <bold>C</bold>) or western blots (<bold>D</bold> and <bold>E</bold>) were performed for the indicated miR-21 targets as described in &#8216;Materials and Methods&#8217; section. The blots shown are representative of three separate biological replicates. The values in (E) are the mean &#177; SEM of three to four separate experiments. (<bold>F</bold>) MCF-7 cells were transfected with siControl RNA or siER&#946; for 48 h prior to treatment with EtOH or 10 nM E<sub>2</sub> for 6 h. MiR-21 expression is the mean fold change &#177; SEM of four samples. Values are mean &#177; SEM. *Significantly different from the EtOH siControl for each protein, <italic>P</italic> &lt; 0.05. **Significantly different from E<sub>2</sub>, PPT or DPN siControl value for that protein, <italic>P</italic> &lt; 0.05.</p>
###xml 1177 2560 1122 2467 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="53">ER&#945;, but not ER&#946;, knockdown inhibits the E<sub>2</sub>-mediated decrease in miR-21 and thus reverses miR-21 target gene expression. (<bold>A</bold>) MCF-7 cells were not transfected (Not TF) or transfected with siControl RNA or siER&#945; as described in &#8216;Materials and Methods&#8217; section for 48 h and WCE were analyzed for ER&#945; and ER&#946; by western blot as described in &#8216;Materials and Methods&#8217; section. The same membrane was stripped and reprobed for &#946;-actin for normalization. The% ER&#945; knockdown was calculated relative to the Not TF control. (<bold>B</bold>) MCF-7 cells were transfected with siControl RNA or siER&#945; for 48 h prior to treatment with EtOH or 10 nM E<sub>2</sub>, PPT, or DPN for 6 h. RNA and protein were extracted and Q-PCR (<bold>B</bold> and <bold>C</bold>) or western blots (<bold>D</bold> and <bold>E</bold>) were performed for the indicated miR-21 targets as described in &#8216;Materials and Methods&#8217; section. The blots shown are representative of three separate biological replicates. The values in (E) are the mean &#177; SEM of three to four separate experiments. (<bold>F</bold>) MCF-7 cells were transfected with siControl RNA or siER&#946; for 48 h prior to treatment with EtOH or 10 nM E<sub>2</sub> for 6 h. MiR-21 expression is the mean fold change &#177; SEM of four samples. Values are mean &#177; SEM. *Significantly different from the EtOH siControl for each protein, <italic>P</italic> &lt; 0.05. **Significantly different from E<sub>2</sub>, PPT or DPN siControl value for that protein, <italic>P</italic> &lt; 0.05.</p></caption>
###xml 2560 2560 2467 2467 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp117f6"/>
###xml 1168 2560 1113 2467 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="53">ER&#945;, but not ER&#946;, knockdown inhibits the E<sub>2</sub>-mediated decrease in miR-21 and thus reverses miR-21 target gene expression. (<bold>A</bold>) MCF-7 cells were not transfected (Not TF) or transfected with siControl RNA or siER&#945; as described in &#8216;Materials and Methods&#8217; section for 48 h and WCE were analyzed for ER&#945; and ER&#946; by western blot as described in &#8216;Materials and Methods&#8217; section. The same membrane was stripped and reprobed for &#946;-actin for normalization. The% ER&#945; knockdown was calculated relative to the Not TF control. (<bold>B</bold>) MCF-7 cells were transfected with siControl RNA or siER&#945; for 48 h prior to treatment with EtOH or 10 nM E<sub>2</sub>, PPT, or DPN for 6 h. RNA and protein were extracted and Q-PCR (<bold>B</bold> and <bold>C</bold>) or western blots (<bold>D</bold> and <bold>E</bold>) were performed for the indicated miR-21 targets as described in &#8216;Materials and Methods&#8217; section. The blots shown are representative of three separate biological replicates. The values in (E) are the mean &#177; SEM of three to four separate experiments. (<bold>F</bold>) MCF-7 cells were transfected with siControl RNA or siER&#946; for 48 h prior to treatment with EtOH or 10 nM E<sub>2</sub> for 6 h. MiR-21 expression is the mean fold change &#177; SEM of four samples. Values are mean &#177; SEM. *Significantly different from the EtOH siControl for each protein, <italic>P</italic> &lt; 0.05. **Significantly different from E<sub>2</sub>, PPT or DPN siControl value for that protein, <italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkp117f6"/></fig>
To confirm the role of ERalpha in the observed decrease in miR-21 and increase in miR-21-target gene expression in response to E2 and PPT, MCF-7 cells were transfected with siRNA targeting ERalpha or control siRNA for 48 h and then treated with EtOH, 10 nM E2, PPT, or DPN for 6 h. Transfection of MCF-7 cells with siRNA for ERalpha reduced ERalpha mRNA expression by approximately62% () and ERalpha protein by 61%. In contrast, ERbeta protein levels were unaffected (Figure 6A, see also ). siERalpha blocked the E2-induced repression of miR-21 (Figure 6B). Concordantly, knockdown of ERalpha reduced the E2-stimulated expression of miR-21 target genes PDCD4, PTEN and BCL2 (Figure 6C). To confirm these findings at the protein level, western blots were performed using antibodies commercially available for Pdcd4, PTEN and Bcl-2 (Figure 6D). Results confirm that ERalpha knockdown reduced the E2- and PPT-induced protein expression of the miR-21 target genes PDCD4, PTEN and BCL2 to basal levels (Figure 6E). siERalpha also reduced DPN-stimulated expression of Pdcd4, PTEN and Bcl-2 proteins suggesting that at least part of the DPN response may be ERalpha-mediated. Figure 6.ERalpha, but not ERbeta, knockdown inhibits the E2-mediated decrease in miR-21 and thus reverses miR-21 target gene expression. (A) MCF-7 cells were not transfected (Not TF) or transfected with siControl RNA or siERalpha as described in 'Materials and Methods' section for 48 h and WCE were analyzed for ERalpha and ERbeta by western blot as described in 'Materials and Methods' section. The same membrane was stripped and reprobed for beta-actin for normalization. The% ERalpha knockdown was calculated relative to the Not TF control. (B) MCF-7 cells were transfected with siControl RNA or siERalpha for 48 h prior to treatment with EtOH or 10 nM E2, PPT, or DPN for 6 h. RNA and protein were extracted and Q-PCR (B and C) or western blots (D and E) were performed for the indicated miR-21 targets as described in 'Materials and Methods' section. The blots shown are representative of three separate biological replicates. The values in (E) are the mean +/- SEM of three to four separate experiments. (F) MCF-7 cells were transfected with siControl RNA or siERbeta for 48 h prior to treatment with EtOH or 10 nM E2 for 6 h. MiR-21 expression is the mean fold change +/- SEM of four samples. Values are mean +/- SEM. *Significantly different from the EtOH siControl for each protein, P < 0.05. **Significantly different from E2, PPT or DPN siControl value for that protein, P < 0.05.
###end p 52
###begin p 53
###xml 49 50 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 129 130 122 123 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 537 538 512 513 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 649 650 620 621 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 715 716 686 687 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 721 722 692 693 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 742 743 713 714 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 748 749 719 720 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1003 1004 972 973 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1114 1115 1080 1081 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1284 1285 1246 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1326 1327 1288 1289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1374 1375 1336 1337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
ERalpha, but not ERbeta, knockdown inhibits the E2-mediated decrease in miR-21 and thus reverses miR-21 target gene expression. (A) MCF-7 cells were not transfected (Not TF) or transfected with siControl RNA or siERalpha as described in 'Materials and Methods' section for 48 h and WCE were analyzed for ERalpha and ERbeta by western blot as described in 'Materials and Methods' section. The same membrane was stripped and reprobed for beta-actin for normalization. The% ERalpha knockdown was calculated relative to the Not TF control. (B) MCF-7 cells were transfected with siControl RNA or siERalpha for 48 h prior to treatment with EtOH or 10 nM E2, PPT, or DPN for 6 h. RNA and protein were extracted and Q-PCR (B and C) or western blots (D and E) were performed for the indicated miR-21 targets as described in 'Materials and Methods' section. The blots shown are representative of three separate biological replicates. The values in (E) are the mean +/- SEM of three to four separate experiments. (F) MCF-7 cells were transfected with siControl RNA or siERbeta for 48 h prior to treatment with EtOH or 10 nM E2 for 6 h. MiR-21 expression is the mean fold change +/- SEM of four samples. Values are mean +/- SEM. *Significantly different from the EtOH siControl for each protein, P < 0.05. **Significantly different from E2, PPT or DPN siControl value for that protein, P < 0.05.
###end p 53
###begin title 54
Effect of ERbeta knock-down on miR-21 expression in MCF-7 cells
###end title 54
###begin p 55
###xml 39 40 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 198 199 192 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 345 346 318 319 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 380 388 353 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 446 451 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 453 457 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 462 466 432 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 487 488 457 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 548 556 518 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 604 608 571 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
To examine ERbeta's role in mediating E2-suppression of miR-21 transcription, MCF-7 cells were transfected with siRNA targeting ERbeta or control siRNA for 48 h and then treated with EtOH or 10 nM E2 for 6 h. siERbeta reduced ERbeta mRNA expression by approximately70% and protein by 64% (). Knockdown of ERbeta reduced basal miR-21 by 73% and E2 treatment had no further effect (Figure 6F). siERbeta resulted in a commensurate increase in basal PDCD4, PTEN and BCL2 mRNA and a loss of E2, DPN and PPT-stimulated PDCD4 and BCL2 transcription ( and Figure 4). With ERbeta knockdown, PPT and DPN increased PTEN mRNA ().
###end p 55
###begin title 56
DISCUSSION
###end title 56
###begin p 57
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 232 233 232 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 400 401 400 401 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 490 495 490 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 497 501 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 506 510 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 614 615 610 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 728 729 724 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 953 954 932 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 983 988 962 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57 B58 B59 B60 B61">57&#8211;61</xref>
###xml 1118 1120 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B62">62</xref>
###xml 1241 1242 1211 1212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1356 1364 1322 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1490 1491 1456 1457 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1570 1571 1536 1537 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1624 1626 1590 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B63">63</xref>
###xml 1670 1672 1636 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 1675 1684 1641 1650 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7.</label>
###xml 1773 1774 1739 1740 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1931 1932 1890 1891 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1960 1964 1915 1919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 2056 2057 2011 2012 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2196 2201 2151 2156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 2203 2207 2158 2162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 2212 2216 2167 2171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 1684 2217 1650 2172 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="58">ER regulates miR-21 expression and its downstream targets in a ligand-dependent manner. E<sub>2</sub>-ER (ER&#945; and/or ER&#946;) inhibits miR-21 expression resulting in a loss of repression (indicated by the Xs) of Pdcd4, PTEN and Bcl-2 protein expression. E<sub>2</sub>-ER&#945; directly increases <italic>BCL2</italic> transcription (arrow, +). 4-OHT and ICI block ER-induced inhibition of miR-21 expression. E<sub>2</sub>-ER also regulates the expression of other miRNAs and mRNAs that, in turn, regulate other cellular pathways which impact the expression of <italic>PDCD4</italic>, <italic>PTEN</italic> and <italic>BCL2</italic>.</p>
###xml 1684 2217 1650 2172 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="58">ER regulates miR-21 expression and its downstream targets in a ligand-dependent manner. E<sub>2</sub>-ER (ER&#945; and/or ER&#946;) inhibits miR-21 expression resulting in a loss of repression (indicated by the Xs) of Pdcd4, PTEN and Bcl-2 protein expression. E<sub>2</sub>-ER&#945; directly increases <italic>BCL2</italic> transcription (arrow, +). 4-OHT and ICI block ER-induced inhibition of miR-21 expression. E<sub>2</sub>-ER also regulates the expression of other miRNAs and mRNAs that, in turn, regulate other cellular pathways which impact the expression of <italic>PDCD4</italic>, <italic>PTEN</italic> and <italic>BCL2</italic>.</p></caption>
###xml 2217 2217 2172 2172 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp117f7"/>
###xml 1675 2217 1641 2172 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F7" position="float"><label>Figure 7.</label><caption><p textid="58">ER regulates miR-21 expression and its downstream targets in a ligand-dependent manner. E<sub>2</sub>-ER (ER&#945; and/or ER&#946;) inhibits miR-21 expression resulting in a loss of repression (indicated by the Xs) of Pdcd4, PTEN and Bcl-2 protein expression. E<sub>2</sub>-ER&#945; directly increases <italic>BCL2</italic> transcription (arrow, +). 4-OHT and ICI block ER-induced inhibition of miR-21 expression. E<sub>2</sub>-ER also regulates the expression of other miRNAs and mRNAs that, in turn, regulate other cellular pathways which impact the expression of <italic>PDCD4</italic>, <italic>PTEN</italic> and <italic>BCL2</italic>.</p></caption><graphic xlink:href="gkp117f7"/></fig>
###xml 302 307 <span type="species:ncbi:9606">human</span>
###xml 520 525 <span type="species:ncbi:9606">human</span>
###xml 1664 1668 <span type="species:ncbi:10090">mice</span>
Since the oncomiR miR-21 was the most significantly up-regulated miRNA in breast tumor biopsies compared to normal breast tissue (37) and because estrogen stimulates breast tumorigenesis, the goal of this study was to determine if E2 regulates the expression of miR-21 in MCF-7 cells as an established human breast cancer model of estrogen responses. To our knowledge, this is the first report that E2 downregulates miR-21 and thus upregulates the protein expression of miR-21 target genes PDCD4, PTEN and BCL2 in MCF-7 human breast cancer cells. Furthermore, the ability of 4-OHT, ICI and siERalpha to block the E2 repression of miR-21 and the subsequent increase in Pdcd4, Pten and Bcl-2 proteins provide a mechanism for the E2 effect, i.e. through ERalpha activation. ERbeta appears to regulate basal miR-21 expression in MCF-7 cells since knockdown of ERbeta reduced miR-21 expression. ERbeta represses/opposes ERalpha transcriptional activity and E2-induced cell proliferation (57-61). Stable transfection of MCF-7 cells with ERbeta inhibited xenograft tumor growth, indicating that ERbeta is a tumor suppressor (62). We observed that ERbeta knock down reduced basal miR-21 and there was no further reduction in miR-21 expression with E2 treatment. These data appear to indicate a relief of repression of ERalpha's inhibition of miR-21 transcription. Figure 7 shows a schematic model illustrating ER regulation of miR-21 and miR-21 regulation of its targets. Our results showing that E2 reduces miR-21 expression in MCF-7 are in agreement with recent reports that E2 down-regulated miR-21 in endometrial stromal cells (63) and in the uterus of ovariectomized mice (64). Figure 7.ER regulates miR-21 expression and its downstream targets in a ligand-dependent manner. E2-ER (ERalpha and/or ERbeta) inhibits miR-21 expression resulting in a loss of repression (indicated by the Xs) of Pdcd4, PTEN and Bcl-2 protein expression. E2-ERalpha directly increases BCL2 transcription (arrow, +). 4-OHT and ICI block ER-induced inhibition of miR-21 expression. E2-ER also regulates the expression of other miRNAs and mRNAs that, in turn, regulate other cellular pathways which impact the expression of PDCD4, PTEN and BCL2.
###end p 57
###begin p 58
###xml 89 90 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 247 248 240 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 276 280 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 372 373 361 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 512 517 501 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 519 523 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 528 532 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
ER regulates miR-21 expression and its downstream targets in a ligand-dependent manner. E2-ER (ERalpha and/or ERbeta) inhibits miR-21 expression resulting in a loss of repression (indicated by the Xs) of Pdcd4, PTEN and Bcl-2 protein expression. E2-ERalpha directly increases BCL2 transcription (arrow, +). 4-OHT and ICI block ER-induced inhibition of miR-21 expression. E2-ER also regulates the expression of other miRNAs and mRNAs that, in turn, regulate other cellular pathways which impact the expression of PDCD4, PTEN and BCL2.
###end p 58
###begin p 59
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 115 116 115 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 386 387 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B67">67</xref>
###xml 854 855 854 855 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 926 931 926 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68 B69 B70 B71 B72">68&#8211;72</xref>
###xml 1065 1066 1065 1066 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1169 1170 1169 1170 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
At the same time, given the established link between estrogen and breast carcinogenesis (65,66), one might expect E2 to upregulate miR-21 rather than inhibit miR-21 as shown here. Likewise, the increase in miR-21 expression by 4-OHT appears to contradict its anticipated anti-tumor role, but is consistent with 4-OHT's gene-specific SERM activity as indicated by its activity opposing E2's inhibition of miR-21 expression. For complex phenotypes including cell proliferation, genes and proteins are up- and down- regulated by a variety of interacting mechanisms that we are only beginning to understand and integrate. Our data are supported by a recent report showing that miR-21 expression was reduced in TAM-resistant MCF-7 cells (67), a finding likely reflecting the loss of ER-regulated responses in TAM-resistant cells. It is well-established that E2 and 4-OHT regulate transcription in a gene- and cell-specific manner (68-72) and the findings reported here add miR-21 to the list of ER-regulated genes. We conclude that our apparent 'contradictory data' of E2 down-regulating and 4-OHT increasing miR-21 expression add unexpected complexity to understanding of E2 action in breast tumorigenesis.
###end p 59
###begin p 60
###xml 51 52 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 391 392 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 424 425 400 401 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 498 500 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B73">73</xref>
###xml 501 503 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B74">74</xref>
###xml 752 760 720 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 762 764 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B75">75</xref>
###xml 913 914 877 878 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 991 996 951 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IKZF1</italic>
###xml 1038 1040 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B76">76</xref>
###xml 1123 1129 1083 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMEM49</italic>
###xml 1208 1209 1168 1169 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1371 1373 1323 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B73">73</xref>
###xml 1397 1398 1349 1350 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1639 1641 1587 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 1880 1882 1821 1823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B77">77</xref>
###xml 1883 1885 1824 1826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B78">78</xref>
###xml 1909 1910 1850 1851 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1925 1931 1866 1872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMEM49</italic>
###xml 1983 1989 1924 1930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TMEM49</italic>
###xml 2030 2032 1971 1973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 2113 2114 2054 2055 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1296 1301 <span type="species:ncbi:9606">human</span>
###xml 1350 1355 <span type="species:ncbi:9606">human</span>
The reduction of miR-21 expression in response to E2 appears to be mediated, in part, by the -1kb promoter. However, because the reduction in transcription was only approximately25% in the reporter assay compared to a approximately80% reduction by Q-PCR analysis of miR-21 expression, it is possible that additional regions are also important in regulating miR-21 expression in response to E2. It has been established that E2 increases ERalpha binding to chromosome regions outside gene promoters (73,74). Analysis of the miR-21 promoter using TRANSFAC () identified a non-consensus ERE with a 2-bp spacer: 5'-AGCTGAgcTGACC-3' located 883-bp upstream of the TATA-binding site. Previous studies showed no binding of ERalpha to an ERE with a 2-bp spacer in vitro (75). However, in addition to direct ERE binding, ERalpha regulates gene transcription by tethering to other transcription factors. Genes repressed by E2-ERalpha in MCF-7 cells lack EREs and instead have binding sites for Ikaros (IKZF1) and PAX homeobox factors, among others (76), that are also located in the miR-21 promoter. miR-21 is located in the 3'UTR of TMEM49 located at 17q23.1. Using data from Myles Brown's online database of genomic E2-ERalpha-binding sites in MCF-7 cells from chromatin immunoprecipitation of ERalpha on-human genome tiled microarray data (ChIP-on-chip) for human chromosome 17 (73) , we found that both E2-ERalpha and RNA polymerase II binding overlap with the 71-bp miR-21 gene (). AP-1 was shown to activate miR-21 transcription by direct interaction with three binding sites in the miR-21 promoter in response to PMA treatment of HL-60 cells (56). Although both ERalpha and ERbeta interact with AP-1 to regulate gene expression, the direction of regulation (up or down) varies depending on the ligand, cell type, chromatin context and neighboring transcription factor-binding events (77,78). Here we showed that E2 did not alter TMEM49 transcription which supports previous results that TMEM49 and miR-21 are independently regulated (56). Further studies will be required to analyze the precise mechanisms mediating E2 repression of miR-21.
###end p 60
###begin p 61
###xml 6 7 6 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASA1</italic>
###xml 119 120 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 305 306 305 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 384 389 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASA1</italic>
###xml 437 442 437 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFB1</italic>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
Both E2 and AS-miR-21 induced RASA1 reporter activity; however, the magnitude of luciferase induction was higher with E2 than AS-miR-21. Although normalized relative luciferase between EtOH versus controlAS transfected cells is an unequal comparison, one possible explanation for this difference is that E2 alters the expression of other genes or pathways that selectively impact the RASA1 reporter compared to the other reporters, e.g. TGFB1 and PDCD4, that show similar luciferase activity.
###end p 61
###begin p 62
###xml 50 51 50 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 107 115 107 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 238 243 238 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B79">79</xref>
###xml 375 380 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 426 427 426 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 573 574 573 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 583 590 583 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 620 625 620 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 663 671 663 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 701 702 701 702 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 731 739 731 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 823 824 815 816 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 884 889 876 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 958 963 950 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDCD4</italic>
###xml 1111 1113 1096 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 1084 1089 <span type="species:ncbi:9606">human</span>
Our data showing the downregulation of miR-21 by E2 correlated with upregulation of PDCD4 RNA and protein (Figure 4B and C) are in agreement with a report that blocking miR-21 using locked nucleic-acid-modified oligonucleotides increased PDCD4 mRNA and protein in MCF-7 cells (79). Furthermore, our results in the transient transfection assays indicate that miR-21 regulates PDCD4 by an MRE in the 3'UTR. The conclusion that E2-increases PDCD4 expression through inhibition of miR-21 expression in MCF-7 cells is further supported by data showing that AS-miR-21 inhibited E2-induced Renilla luciferase activity from the PDCD4 MRE and 3'-UTR in transfected MCF-7 (Figure 2B) and that AS-miR-21 mimics E2-induction of Pdcd4 protein (Figure 5C). Our ERalpha knockdown experiments indicate that ERalpha is responsible for the E2-mediated inhibition of miR-21 expression and regulation of PDCD4 as well as other miR-21 target genes. The DPN- induced reduction in PDCD4 mRNA aligns with a report that DPN-activated ERbeta inhibits the transcription of PPT-activated ERalpha target genes in human breast cancer cells (57). The increase seen in Pdcd4 protein after 24 h of DPN treatment may result from a secondary gene effect.
###end p 62
###begin p 63
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 227 235 227 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 338 339 338 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 377 381 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 426 430 426 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B80">80</xref>
###xml 529 533 529 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 601 602 597 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 613 617 609 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 686 688 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B81">81</xref>
###xml 732 736 724 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 760 761 752 753 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 908 912 896 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL2</italic>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
miR-21 functions as an oncogene and modulates tumorigenicity through regulation of Bcl-2 in MCF-7 cells (38). Inhibition of miR-21 expression by AS-miR-21 reduced Bcl-2 protein expression and increased apoptosis in MCF-7 cells in vitro and in tumor xenografts in mice (38). Consistent with these findings, our data demonstrate that both E2 and PPT decrease miR-21 and increase BCL2 mRNA and protein expression in MCF-7 cells. BCL2 expression has long been considered a good prognostic marker in breast cancer (80). DPN increased BCL2 mRNA and protein expression; likely by ERalpha activation because E2 regulates BCL2 transcription in MCF-7 cells via ERalpha- Sp1 and AP1 interactions (81), we can not conclude that the increase in BCL2 mRNA is due solely to E2-mediated decreased miR-21. Further studies will be needed to dissect the relative contributions of multiple ERalpha-mediated pathways controlling BCL2 gene expression.
###end p 63
###begin p 64
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 39 41 39 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B82">82</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B83">83</xref>
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B84">84</xref>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 292 293 292 293 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 379 387 379 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 470 471 466 467 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 515 516 511 512 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 537 541 533 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 689 693 678 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 718 719 707 708 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 750 754 739 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 861 865 850 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 978 982 964 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 1030 1031 1016 1017 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1042 1044 1028 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B85">85</xref>
###xml 1114 1115 1100 1101 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 138 143 <span type="species:ncbi:9606">human</span>
PTEN is an important tumor suppressor (82) that has been identified as a breast cancer susceptibility gene (83). miR-21 regulates PTEN in human hepatocellular cancer cells and tumors (35,84) but to our knowledge, no one has examined miR-21 regulation of PTEN in breast cancer. We found that E2, PPT and DPN increased PTEN protein levels without affecting PTEN transcript levels (Figure 4), indicating translational inhibition. Knockdown of ERalpha by siRNA blocked the E2-mediated downregulation of miR-21 and the E2-induced increase in PTEN, indicating that this effect is mediated via ERalpha, and commensurate with downregulation of miR-21. With ERbeta knockdown, PPT and DPN increased PTEN mRNA; however, because E2, PPT and DPN did not regulate PTEN mRNA in MCF-7 cells, it is likely that this increase is mediated by the loss of the expression of another PTEN transcriptional repressor with ERbeta knockdown. Our data contradict a previous report showing no alteration of PTEN expression in MCF-7 cells treated with 100 nM E2 for 24 h (85). This difference may be due to the lower, physiologically relevant E2 concentration and shorter treatment time used here.
###end p 64
###begin p 65
###xml 87 88 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In summary, we report for the first time that miR-21 is down-regulated in response to E2 in an ERalpha-dependent manner and that ERbeta regulates basal miR-21 expression. Furthermore, this inhibition correlates with up-regulation of miR-21 targets: PDCD4, PTEN and Bcl-2. The identification of miR-21 as a miRNA regulated by ER may open new avenues for potential therapeutic intervention in breast cancer treatment.
###end p 65
###begin title 66
FUNDING
###end title 66
###begin p 67
###xml 0 29 0 29 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</grant-sponsor>
###xml 29 41 29 41 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R21 CA124811</grant-num>
###xml 296 325 296 325 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</grant-sponsor>
###xml 325 337 325 337 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R21 CA124811</grant-num>
National Institutes of HealthR21 CA124811 and an Intramural Research Incentive Grant from the Office of the Senior Vice President for Research [to C.M.K.]. Pre-doctoral fellowship from National Institutes of Environmental Health Sciences T32 ES011564 [to K.A.R.]. Funding for open access charge: National Institutes of HealthR21 CA124811 to C.M.K.
###end p 67
###begin p 68
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 68
###begin title 69
Supplementary Material
###end title 69
###begin title 70
[Supplementary Data]
###end title 70
###begin title 71
ACKNOWLEDGEMENTS
###end title 71
###begin p 72
We thank Dr Bryan R. Cullen for providing the pri-miR-21 promoter luciferase reporter constructs used in this study. We thank Jeremy S. Harbour and Abirami Krishnasamy for helping with western blots. We thank Drs Barbara J. Clark and Nancy C. Martin for their comments to improve this manuscript. Thanks to Drs Myles Brown and Mathieu Lupien from Harvard University and Dr Ted Kalbflesich (UofL) for their help with the genome analysis for Supplementary Figure 6.
###end p 72
###begin title 73
REFERENCES
###end title 73
###begin article-title 74
Oestrogen receptor function at classical and alternative response elements
###end article-title 74
###begin article-title 75
###xml 80 85 <span type="species:ncbi:9606">human</span>
Transcriptional activation of thymidylate synthase by 17beta-estradiol in MCF-7 human breast cancer cells
###end article-title 75
###begin article-title 76
Nuclear receptor coregulators: cellular and molecular biology
###end article-title 76
###begin article-title 77
Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression
###end article-title 77
###begin article-title 78
Integration of the extranuclear and nuclear actions of estrogen
###end article-title 78
###begin article-title 79
Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues
###end article-title 79
###begin article-title 80
Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study
###end article-title 80
###begin article-title 81
Treatment of postmenopausal breast cancer with selective estrogen receptor modulators (SERMs)
###end article-title 81
###begin article-title 82
New developments in the treatment of postmenopausal breast cancer
###end article-title 82
###begin article-title 83
Ribo-gnome: the big world of small RNAs
###end article-title 83
###begin article-title 84
Principles of micro-RNA production and maturation
###end article-title 84
###begin article-title 85
Genetics. Erasing microRNAs reveals their powerful punch
###end article-title 85
###begin article-title 86
MicroRNAs and endocrine biology
###end article-title 86
###begin article-title 87
Switching from repression to activation: microRNAs can up-regulate translation
###end article-title 87
###begin article-title 88
###xml 20 25 <span type="species:ncbi:9606">human</span>
Genomic analysis of human microRNA transcripts
###end article-title 88
###begin article-title 89
###xml 35 40 <span type="species:ncbi:9606">human</span>
A microRNA expression signature of human solid tumors defines cancer gene targets
###end article-title 89
###begin article-title 90
###xml 56 61 <span type="species:ncbi:9606">human</span>
microRNAs exhibit high frequency genomic alterations in human cancer
###end article-title 90
###begin article-title 91
###xml 42 47 <span type="species:ncbi:9606">human</span>
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
###end article-title 91
###begin article-title 92
MicroRNAs as oncogenes
###end article-title 92
###begin article-title 93
###xml 65 70 <span type="species:ncbi:9606">human</span>
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation
###end article-title 93
###begin article-title 94
###xml 41 46 <span type="species:ncbi:9606">human</span>
MicroRNA gene expression deregulation in human breast cancer
###end article-title 94
###begin article-title 95
###xml 57 62 <span type="species:ncbi:9606">human</span>
Real-time expression profiling of microRNA precursors in human cancer cell lines
###end article-title 95
###begin article-title 96
RAS is regulated by the let-7 microRNA family
###end article-title 96
###begin article-title 97
###xml 36 41 <span type="species:ncbi:9606">human</span>
Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing
###end article-title 97
###begin article-title 98
Rapid alteration of microRNA levels by histone deacetylase inhibition
###end article-title 98
###begin article-title 99
Extensive post-transcriptional regulation of microRNAs and its implications for cancer
###end article-title 99
###begin article-title 100
###xml 55 60 <span type="species:ncbi:9606">human</span>
The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-{alpha} (ER{alpha}) and represses ER{alpha} messenger RNA and protein expression in breast cancer cell lines
###end article-title 100
###begin article-title 101
###xml 33 38 <span type="species:ncbi:9606">human</span>
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
###end article-title 101
###begin article-title 102
###xml 82 87 <span type="species:ncbi:9606">human</span>
Characterization of microRNA expression levels and their biological correlates in human cancer cell lines
###end article-title 102
###begin article-title 103
###xml 29 34 <span type="species:ncbi:9606">human</span>
miRNA genetic alterations in human cancers
###end article-title 103
###begin article-title 104
###xml 75 80 <span type="species:ncbi:9606">human</span>
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma
###end article-title 104
###begin article-title 105
Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin
###end article-title 105
###begin article-title 106
###xml 60 65 <span type="species:ncbi:9606">human</span>
The let-7 microRNA represses cell proliferation pathways in human cells
###end article-title 106
###begin article-title 107
###xml 60 65 <span type="species:ncbi:9606">human</span>
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells
###end article-title 107
###begin article-title 108
###xml 70 75 <span type="species:ncbi:9606">human</span>
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
###end article-title 108
###begin article-title 109
MicroRNAs in biological processes and carcinogenesis
###end article-title 109
###begin article-title 110
Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer
###end article-title 110
###begin article-title 111
miR-21-mediated tumor growth
###end article-title 111
###begin article-title 112
Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer
###end article-title 112
###begin article-title 113
Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies
###end article-title 113
###begin article-title 114
Computational analysis of biological functions and pathways collectively targeted by co-expressed microRNAs in cancer
###end article-title 114
###begin article-title 115
Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA
###end article-title 115
###begin article-title 116
MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
###end article-title 116
###begin article-title 117
Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis
###end article-title 117
###begin article-title 118
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs
###end article-title 118
###begin article-title 119
Potential benefits of estrogens and progestogens on breast cancer
###end article-title 119
###begin article-title 120
###xml 23 28 <span type="species:ncbi:9606">human</span>
Estrogen receptors and human disease
###end article-title 120
###begin article-title 121
Comparative analyses of mechanistic differences among antiestrogens
###end article-title 121
###begin article-title 122
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators
###end article-title 122
###begin article-title 123
Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression
###end article-title 123
###begin article-title 124
###xml 117 122 <span type="species:ncbi:9606">human</span>
Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells
###end article-title 124
###begin article-title 125
###xml 65 70 <span type="species:ncbi:9606">human</span>
Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation
###end article-title 125
###begin article-title 126
Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells
###end article-title 126
###begin article-title 127
Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cells
###end article-title 127
###begin article-title 128
MicroRNA targeting specificity in mammals: determinants beyond seed pairing
###end article-title 128
###begin article-title 129
miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism
###end article-title 129
###begin article-title 130
###xml 97 102 <span type="species:ncbi:9606">human</span>
Influence of cellular ER{alpha}/ER{beta} ratio on the ER{alpha}-agonist induced proliferation of human T47D breast cancer cells
###end article-title 130
###begin article-title 131
Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer
###end article-title 131
###begin article-title 132
Estrogen receptor (ER) {beta} modulates ER{alpha}-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters
###end article-title 132
###begin article-title 133
###xml 118 124 <span type="species:ncbi:10090">murine</span>
Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11
###end article-title 133
###begin article-title 134
Estrogen receptor {beta} inhibits 17{beta}-estradiol-stimulated proliferation of the breast cancer cell line T47D
###end article-title 134
###begin article-title 135
Loss of tumourigenicity of stably ER[beta]-transfected MCF-7 breast cancer cells
###end article-title 135
###begin article-title 136
The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression
###end article-title 136
###begin article-title 137
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
MicroRNA expression and regulation in mouse uterus during embryo implantation
###end article-title 137
###begin article-title 138
###xml 62 67 <span type="species:ncbi:9606">human</span>
17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells
###end article-title 138
###begin article-title 139
###xml 29 34 <span type="species:ncbi:9606">human</span>
Neoplastic transformation of human breast epithelial cells by estrogens and chemical carcinogens
###end article-title 139
###begin article-title 140
MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27(Kip1)
###end article-title 140
###begin article-title 141
Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome
###end article-title 141
###begin article-title 142
###xml 64 69 <span type="species:ncbi:9606">human</span>
Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype
###end article-title 142
###begin article-title 143
Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells
###end article-title 143
###begin article-title 144
Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor
###end article-title 144
###begin article-title 145
Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines
###end article-title 145
###begin article-title 146
Genome-wide analysis of estrogen receptor binding sites
###end article-title 146
###begin article-title 147
###xml 96 101 <span type="species:ncbi:9606">human</span>
Sensitive ChIP-DSL technology reveals an extensive estrogen receptor {alpha}-binding program on human gene promoters
###end article-title 147
###begin article-title 148
A microtiter well assay for quantitative measurement of estrogen receptor binding to estrogen-responsive elements
###end article-title 148
###begin article-title 149
Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells
###end article-title 149
###begin article-title 150
Estrogen signaling multiple pathways to impact gene transcription
###end article-title 150
###begin article-title 151
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways
###end article-title 151
###begin article-title 152
Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells
###end article-title 152
###begin article-title 153
Bcl-2 gene family and related proteins in mammary gland involution and breast cancer
###end article-title 153
###begin article-title 154
Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells
###end article-title 154
###begin article-title 155
Why is PTEN an important tumor suppressor?
###end article-title 155
###begin article-title 156
Genetic susceptibility to breast cancer
###end article-title 156
###begin article-title 157
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
###end article-title 157
###begin article-title 158
Estrogen receptor {alpha} binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor {gamma} signaling in breast cancer cells
###end article-title 158

